≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Gastrointestinal stromal tumor and sarcoma

Endpoint Browser PheWeb

C3_GASTRINT_STROM

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cancer registry: Topography ICD-O-3 — ANY
  • Cancer registry: Morphology ICD-O-3 — 8936
  • Cancer registry: Behaviour codes — ANY

1 out of 7 registries used, show all original rules.

448

4. Check minimum number of events

None

448

5. Include endpoints

None

448

6. Filter based on genotype QC (FinnGen only)

436

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF8

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 436 207 229
Unadjusted period prevalence (%) 0.09 0.07 0.11
Median age at first event (years) 68.30 67.11 69.39

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
448
Matched controls
4480
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
230.8
201
*
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
1435.8
195.1
176
*
189
Kela drug reimbursment
Imatinib
+∞
180.8
161
*
JN4BD
NOMESCO Finland
Extensive body CT
21.7
167.2
139
91
WX302
NOMESCO Finland
Thoracal epidural anesthesy
32.3
151.8
103
41
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
34.5
151.0
100
37
L01XE01
ATC
[U] imatinib
+∞
147.2
133
*
JDA63
NOMESCO Finland
Local excision of lesion of stomach
+∞
146.0
132
*
JN4AD
NOMESCO Finland
Body CT examination
14.5
139.8
149
149
C49.49
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor
+∞
121.5
111
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
9.1
115.4
320
963
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
37.1
112.9
72
23
JN3BD
NOMESCO Finland
Extensive abdominal CT
10.2
112.1
158
228
8936/3-C16.9
ICD-O-3
Gastrointestinal stromal tumor of stomach, NOS
+∞
110.0
101
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
15.1
107.8
105
89
8936/1-C16.9
ICD-O-3
Gastrointestinal stromal tumor, NOS, of stomach, NOS
+∞
107.8
99
*
A03FA01
ATC
metoclopramide; systemic, rectal
8.3
98.1
170
308
L01EA01
ATC
imatinib; oral
+∞
97.5
90
*
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
56.2
87.4
50
10
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
17.8
82.9
71
47
JN3AD
NOMESCO Finland
Abdominal CT examination
7.1
78.8
152
302
H02AB02
ATC
dexamethasone; systemic
28.6
74.2
51
20
316
Kela drug reimbursment
Imatinib
+∞
72.9
68
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
16.0
72.2
65
47
JN4CD
NOMESCO Finland
Very extensive body CT
24.9
70.4
51
23
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
203.2
68.2
69
*
WX408
NOMESCO Finland
General anesthesy, balanced
5.1
63.9
208
647
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
674.8
61.3
59
*
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
+∞
59.7
56
*
JFB00
NOMESCO Finland
Partial resection of small intestine
82.5
57.9
64
9
WZC30
NOMESCO Finland
Teaching
5.4
54.2
134
326
B01AB05
ATC
enoxaparin; parenteral
4.4
53.4
238
918
C61
ICD-10 Finland
Malignant neoplasm of prostate
545.7
50.4
49
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
47.8
45
*
XX3DW
NOMESCO Finland
Time consuming IT work
8.0
47.6
70
101
WZC00
NOMESCO Finland
Treatment plan or consultation
4.0
46.4
215
834
A04AA02
ATC
granisetron; systemic, transdermal
471.2
44.0
43
*
TPH07
NOMESCO Finland
Cathetrisation of artery
5.1
43.8
112
277
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
43.4
41
*
WX402
NOMESCO Finland
General anaesthesia
4.2
41.7
152
493
Z51.5
ICD-10 Finland
Palliative care
7.5
40.2
62
94
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
39.1
37
*
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
37.0
35
*
WF002
NOMESCO Finland
Radical radiotherapy
138.0
36.3
38
*
WB501
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of primary tumour
+∞
34.8
33
*
JAH00
NOMESCO Finland
Laparotomy
11.4
34.4
37
35
197
Kela drug reimbursment
Sunitinib
+∞
33.8
32
*
A04AA01
ATC
ondansetron; systemic, rectal
10.1
33.2
39
42
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.4
32.8
58
101
C49.4
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of abdomen
+∞
31.6
30
*
WW500
NOMESCO Finland
Blood transfusion
11.1
30.1
33
32
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
114.6
30.1
32
*
R4190
NOMESCO Finland
Nutritional therapy
9.5
29.3
36
41
8936/3-C17.9
ICD-O-3
Gastrointestinal stromal tumor of small intestine, NOS
+∞
28.4
27
*
116
Kela drug reimbursment
Prostate cancer
+∞
28.4
27
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
11.9
27.8
29
26
B01AB10
ATC
tinzaparin; parenteral
4.3
27.4
80
215
115
Kela drug reimbursment
Breast cancer
+∞
27.4
26
*
8936/1-C17.9
ICD-O-3
Gastrointestinal stromal tumor, NOS, of small intestine, NOS
+∞
27.4
26
*
A02BC02
ATC
pantoprazole; systemic
3.9
27.2
375
2551
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
103.2
27.0
29
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.9
26.8
213
1066
B01AB04
ATC
dalteparin; parenteral
6.6
26.8
45
74
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
10.3
25.3
29
30
WF049
NOMESCO Finland
Radiotherapy of metastasis
264.1
24.9
25
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
24.6
92
294
K92.1
ICD-10 Finland
Melaena
4.7
24.6
61
144
JDW97
NOMESCO Finland
Other laparoscopic operation on stomach or duodenum
+∞
24.2
23
*
ZXC86
NOMESCO Finland
Use of endoscopic device
91.9
23.9
26
*
ZXE20
NOMESCO Finland
More than three and less than five hours
3.5
23.7
96
323
322
Kela drug reimbursment
Sunitinib
+∞
23.1
22
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
22.1
21
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
6.3
21.7
38
65
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
8.0
21.5
30
40
L01BC06
ATC
capecitabine; oral
+∞
21.0
20
*
UJF32
NOMESCO Finland
Coloscopy
2.7
20.4
163
795
N02AA05
ATC
oxycodone; systemic
3.0
20.3
111
444
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
20.2
274
1712
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.8
20.2
67
196
8936/3-C26.9
ICD-O-3
Gastrointestinal stromal tumor of gastrointestinal tract, NOS
+∞
19.9
19
*
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
+∞
19.9
19
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
19.9
19
*
176
Kela drug reimbursment
Regorafenib
+∞
19.9
19
*
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
109.9
19.7
21
*
L02AE02
ATC
leuprorelin; implant, parenteral
109.9
19.7
21
*
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
19.8
18.9
28
15
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
18.9
18
*
C17.1
ICD-10 Finland
Malignant neoplasm: Jejunum
+∞
18.9
18
*
C16.29
ICD-10 Finland
Malignant tumor of the corpus ventriculi other or unspecified carcinoma
+∞
18.9
18
*
L01EX01
ATC
sunitinib; oral
+∞
18.9
18
*
L02BG04
ATC
letrozole; oral
73.1
18.9
21
*
HA1AA
NOMESCO Finland
X-ray mammography
6.0
18.8
34
60
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
24.0
17.9
25
11
L01XE04
ATC
[U] sunitinib
+∞
17.8
17
*
369
Kela drug reimbursment
Regorafenib
+∞
17.8
17
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
17.8
17
*
JDC97
NOMESCO Finland
Laparoscopic partial gastrectomy with other reconstruction
+∞
17.8
17
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
187.1
17.6
18
*
ZXE00
NOMESCO Finland
One hour or less
2.4
17.3
199
1131
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
16.8
16
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
176.3
16.6
17
*
R4110
NOMESCO Finland
Physiotherapy
2.4
16.3
151
776
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.5
16.0
32
62
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
15.8
101
434
C17.2
ICD-10 Finland
Malignant neoplasm: Ileum
+∞
15.7
15
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
15.7
15
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
15.5
126
608
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.7
15.2
36
81
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
5.5
15.1
30
58
NK6AN
NOMESCO Finland
Total body bone isotope imaging
58.7
14.9
17
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
14.7
14
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
14.7
14
*
Y77
ICPC
Malignant neoplasm prostate
154.8
14.5
15
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
37.4
14.5
18
5
JKA20
NOMESCO Finland
Cholecystectomy
5.9
14.3
26
46
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
13.6
13
*
L01EX05
ATC
regorafenib; oral
+∞
13.6
13
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
144.2
13.5
14
*
JFA73
NOMESCO Finland
Excision of lesion of small intestine
144.2
13.5
14
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
13.5
191
1155
R10.0
ICD-10 Finland
Acute abdomen
5.6
13.4
26
49
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.4
12.8
26
51
UJD02
NOMESCO Finland
Gastroscopy
3.7
12.7
42
122
L03AA13
ATC
pegfilgrastim; parenteral
72.0
12.7
14
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
10.5
12.6
24
24
C16.09
ICD-10 Finland
Malignant tumor of cardiac or other unspecified carcinoma
+∞
12.6
12
*
8936/1-C17.0
ICD-O-3
Gastrointestinal stromal tumor, NOS, of duodenum
+∞
12.6
12
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
12.6
12
*
8936/3-C16.3
ICD-O-3
Gastrointestinal stromal tumor of gastric antrum
+∞
12.6
12
*
8936/3-C17.1
ICD-O-3
Gastrointestinal stromal tumor of jejunum
+∞
12.6
12
*
8936/3-C16.2
ICD-O-3
Gastrointestinal stromal tumor of body of stomach
+∞
12.6
12
*
JDC96
NOMESCO Finland
Partial gastrectomy with other reconstruction
+∞
12.6
12
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
12.6
12
*
8936/3-C17.2
ICD-O-3
Gastrointestinal stromal tumor of ileum
+∞
12.6
12
*
L01XX28
ATC
[U] imatinib
+∞
12.6
12
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
133.6
12.5
13
*
D64.9
ICD-10 Finland
Anaemia, unspecified
2.7
12.3
74
307
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
4.5
11.9
30
71
JAH01
NOMESCO Finland
Laparoscopy
4.6
11.9
29
67
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
5.3
11.9
24
47
R50.9
ICD-10 Finland
Fever, unspecified
2.6
11.7
78
339
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
31.0
11.7
15
5
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
19.6
11.7
17
9
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
11.5
11.7
21
19
JAL30
NOMESCO Finland
Omentectomy
23.6
11.6
16
7
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
11.5
11
*
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
+∞
11.5
11
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
+∞
11.5
11
*
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
123.0
11.5
12
*
ZX120
NOMESCO Finland
Intravenous
3.4
11.4
42
131
N02AX02
ATC
tramadol; systemic, rectal
2.0
11.0
218
1459
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.9
10.9
53
195
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
10.0
10.9
21
22
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
10.6
168
1037
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
10.5
10
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
10.5
10
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
10.5
10
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
10.5
10
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
10.5
10
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
10.5
10
*
8936/1-C17.1
ICD-O-3
Gastrointestinal stromal tumor, NOS, of jejunum
+∞
10.5
10
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
10.5
10
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
10.5
10
*
8936/3-C16.1
ICD-O-3
Gastrointestinal stromal tumor of fundus of stomach
+∞
10.5
10
*
8936/3-C20.9
ICD-O-3
Gastrointestinal stromal tumor of rectum, NOS
+∞
10.5
10
*
A79
ICPC
Malignancy NOS
+∞
10.5
10
*
D13.3
ICD-10 Finland
Benign neoplasm: Other and unspecified parts of small intestine
24.0
10.3
14
6
K92.0
ICD-10 Finland
Haematemesis
5.0
10.1
22
46
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.2
10.1
101
525
ZX090
NOMESCO Finland
Other technic of radiotherapy
41.0
10.0
12
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.8
9.8
31
87
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
56.2
9.7
11
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.9
9.6
29
79
C17.0
ICD-10 Finland
Malignant neoplasm: Duodenum
+∞
9.4
9
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
9.4
9
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
9.4
9
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
9.4
9
*
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
+∞
9.4
9
*
N02BE01
ATC
paracetamol; systemic, rectal
3.0
9.1
414
3606
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.6
9.1
30
87
JEA00
NOMESCO Finland
Appendectomy
3.6
9.1
30
87
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
9.1
59
253
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
37.5
9.1
11
*
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
19.1
9.0
13
7
R31
ICD-10 Finland
Unspecified haematuria
2.4
8.9
64
287
J01MA12
ATC
levofloxacin; systemic
2.1
8.7
93
494
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
91.7
8.4
9
*
JFB01
NOMESCO Finland
Laparoscopic partial resection of small intestine
91.7
8.4
9
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
8.4
8
*
C16.19
ICD-10 Finland
Malignant tumor of the fundus ventriculi other or unspecified carcinoma
+∞
8.4
8
*
8936/1-C16.3
ICD-O-3
Gastrointestinal stromal tumor, NOS, of gastric antrum
+∞
8.4
8
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
8.4
8
*
JDD00
NOMESCO Finland
Total gastrectomy and Roux-en-Y oesophagojejunostomy
+∞
8.4
8
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
8.4
8
*
8936/3-C17.0
ICD-O-3
Gastrointestinal stromal tumor of duodenum
+∞
8.4
8
*
JDW96
NOMESCO Finland
Other operation on stomach or duodenum
+∞
8.4
8
*
WB303
NOMESCO Finland
Simple adjuvant therapy of malignancy with biomodifiers
+∞
8.4
8
*
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
+∞
8.4
8
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
8.4
8
*
8936/3-C16.0
ICD-O-3
Gastrointestinal stromal tumor of cardia, NOS
+∞
8.4
8
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.5
8.3
54
231
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.5
8.2
29
88
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
17.6
8.1
12
7
WX600
NOMESCO Finland
Single shot through catheter
13.3
7.9
13
10
XX2RW, ,
NOMESCO Finland
13.3
7.9
13
10
JDH50
NOMESCO Finland
Local excision of lesion of duodenal bulb
45.8
7.7
9
*
JDC20
NOMESCO Finland
Partial gastrectomy and Roux-en-Y reconstruction
45.8
7.7
9
*
UJF30
NOMESCO Finland
Ileoscopy through colon
2.4
7.5
56
255
L03AA02
ATC
filgrastim; parenteral
81.4
7.4
8
*
WX306
NOMESCO Finland
Lumbar epidural anesthesy
3.5
7.4
25
74
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
9.6
7.3
14
15
C16.39
ICD-10 Finland
Malignant tumor of the antrum ventriculi other or unspecified carcinoma
+∞
7.3
7
*
C16.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of stomach
+∞
7.3
7
*
8936/1-C26.9
ICD-O-3
Gastrointestinal stromal tumor, NOS, of gastrointestinal tract, NOS
+∞
7.3
7
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
7.3
7
*
JLC10
NOMESCO Finland
Distal pancreatectomy
+∞
7.3
7
*
8936/1-C16.2
ICD-O-3
Gastrointestinal stromal tumor, NOS, of body of stomach
+∞
7.3
7
*
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
7.3
7
*
L02BB03
ATC
bicalutamide; oral
+∞
7.3
7
*
D77
ICPC
Malignant digestive neopl other/NOS
+∞
7.3
7
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
7.3
7
*
C26.0
ICD-10 Finland
Malignant neoplasm: Intestinal tract, part unspecified
+∞
7.3
7
*
8936/1-C17.2
ICD-O-3
Gastrointestinal stromal tumor, NOS, of ileum
+∞
7.3
7
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
7.3
7
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
7.3
7
*
ZXC96
NOMESCO Finland
Robot assisted procedure
16.1
7.3
11
7
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
30.5
7.2
9
*
Z98.8
ICD-10 Finland
Other specified postsurgical states
8.1
7.2
15
19
WX892
NOMESCO Finland
Monitored bed care
2.5
7.0
44
185
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
3.8
7.0
21
57
Z2221
NOMESCO Finland
Medical doctor
1.8
7.0
116
713
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
40.7
6.8
8
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
17.0
6.8
10
6
JDA32
NOMESCO Finland
Endoscopic injection in stomach or pylorus
17.0
6.8
10
6
JFB30
NOMESCO Finland
Right hemicolectomy
17.0
6.8
10
6
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
6.7
153
1030
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
12.5
6.6
11
9
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.0
6.5
29
102
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
6.5
81
453
ZX070
NOMESCO Finland
Intensity modified radiotherapy
70.8
6.4
7
*
L02BA01
ATC
tamoxifen; oral
70.8
6.4
7
*
WZC15, ,
NOMESCO Finland
70.8
6.4
7
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
70.8
6.4
7
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.2
6.4
25
81
K25.0
ICD-10 Finland
Gastric ulcer, Acute with haemorrhage
8.3
6.4
13
16
C03CA01
ATC
furosemide; systemic
1.7
6.3
162
1124
KCD02
NOMESCO Finland
Transurethral resection of bladder
18.3
6.3
9
5
JDA42
NOMESCO Finland
Other endoscopic haemostatic procedure in stomach or pylorus
18.3
6.3
9
5
E0000UV, ,
ATC
1.7
6.3
181
1295
C16.00
ICD-10 Finland
Cardia
+∞
6.3
6
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
6.3
6
*
C49.40
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen without histology
+∞
6.3
6
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
6.3
6
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
6.3
6
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
6.3
6
*
8936/1-C16.0
ICD-O-3
Gastrointestinal stromal tumor, NOS, of cardia, NOS
+∞
6.3
6
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
6.3
6
*
L01XE21
ATC
[U] regorafenib
+∞
6.3
6
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
6.3
6
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
6.3
6
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
6.3
6
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
6.3
6
*
JDA00
NOMESCO Finland
Gastrotomy
+∞
6.3
6
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
6.3
6
*
JDA22
NOMESCO Finland
Endoscopic ligature of varices of stomach
+∞
6.3
6
*
JD1EE
NOMESCO Finland
Ultrasound examination of gastro-oesophageal reflux
+∞
6.3
6
*
2377A
ICD-9 Finland
Neoplasm of uncertain behaviour of endocrine glands and nervous system, Neurofibromatosis
+∞
6.3
6
*
L02BG03
ATC
anastrozole; oral
+∞
6.3
6
*
L02BX02
ATC
degarelix; parenteral
+∞
6.3
6
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
6.3
6
*
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
+∞
6.3
6
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
6.3
6
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
6.3
6
*
G04BE03
ATC
sildenafil; oral
27.1
6.2
8
*
107
Kela drug reimbursment
Pernicious anaemia
5.9
6.2
16
28
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
7.8
6.2
13
17
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
3.9
6.1
18
48
TKE00
NOMESCO Finland
Needle biopsy of prostate
4.0
6.0
17
44

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Upper gastrointestinal surgery
106 [44777669]
5.7e-01
3.0e+00
5.6e+00
—
5.4e+00
3.7e+00
2.5e+00
cases:16.11%
controls:9.76%
cases:40.94%
controls:3.29%
cases:54.36%
controls:0.45%
—
—
cases:51.94%
controls:0.49%
cases:53.72%
controls:2.88%
cases:55.07%
controls:9.25%
72
436
375
4029
183
147
264
4318
243
20
204
4445
—
228
22
211
4442
231
127
199
4286
190
342
155
3356
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
6.8e-01
3.3e+00
4.7e+00
1.0e+50
3.6e+00
2.7e+00
1.8e+00
cases:9.84%
controls:5.22%
cases:30.43%
controls:1.52%
cases:16.33%
controls:0.18%
cases:6.26%
controls:0.00%
cases:5.24%
controls:0.16%
cases:15.12%
controls:1.16%
cases:23.77%
controls:5.03%
44
233
403
4232
136
68
311
4397
73
8
374
4457
28
0
419
4465
23
7
416
4457
65
51
365
4362
82
186
263
3512
enoxaparin; parenteral
B01AB05 [21600976]
1.2e-02
1.4e+00
3.8e+00
—
5.4e+00
2.6e+00
1.1e+00
cases:5.59%
controls:5.53%
cases:4.92%
controls:1.23%
cases:6.71%
controls:0.16%
—
—
cases:22.32%
controls:0.13%
cases:12.79%
controls:1.11%
cases:13.33%
controls:4.71%
25
247
422
4218
22
55
425
4410
30
7
417
4458
—
98
6
341
4458
55
49
375
4364
46
174
299
3524
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
1.8e-01
2.6e+00
4.4e+00
—
3.8e+00
2.3e+00
1.1e+00
cases:1.79%
controls:1.50%
cases:6.49%
controls:0.54%
cases:11.41%
controls:0.16%
—
—
cases:5.01%
controls:0.11%
cases:7.21%
controls:0.75%
cases:7.83%
controls:2.73%
8
67
439
4398
29
24
418
4441
51
7
396
4458
—
22
5
417
4459
31
33
399
4380
27
101
318
3597
Oncology Clinic/Center
261QX0200X [38004268]
3.2e+00
4.2e+00
—
1.0e+50
1.0e+50
3.8e+00
2.9e+00
cases:6.94%
controls:0.31%
cases:8.28%
controls:0.13%
—
—
cases:99.55%
controls:0.00%
cases:1.14%
controls:0.00%
cases:4.65%
controls:0.11%
cases:8.41%
controls:0.51%
31
14
416
4451
37
6
410
4459
—
445
0
2
4465
5
0
434
4464
20
5
410
4408
29
19
316
3679
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
3.9e-01
2.1e+00
4.6e+00
—
3.6e+00
2.3e+00
1.3e+00
cases:2.68%
controls:1.84%
cases:7.16%
controls:0.90%
cases:10.29%
controls:0.11%
—
—
cases:5.47%
controls:0.16%
cases:7.44%
controls:0.84%
cases:10.14%
controls:3.00%
12
82
435
4383
32
40
415
4425
46
5
401
4460
—
24
7
415
4457
32
37
398
4376
35
111
310
3587
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2.9e-01
1.6e+00
4.4e+00
1.0e+50
4.2e+00
2.1e+00
8.3e-01
cases:2.68%
controls:2.02%
cases:5.59%
controls:1.16%
cases:10.96%
controls:0.16%
cases:6.26%
controls:0.00%
cases:12.07%
controls:0.20%
cases:10.00%
controls:1.29%
cases:11.59%
controls:5.41%
12
90
435
4375
25
52
422
4413
49
7
398
4458
28
0
419
4465
53
9
386
4455
43
57
387
4356
40
200
305
3498
Outpatient Visit
OP [9202]
1.5e-01
8.7e-01
1.9e+00
4.1e+00
2.1e+00
1.9e+00
2.1e+00
cases:80.09%
controls:77.60%
cases:75.62%
controls:56.48%
cases:44.52%
controls:11.18%
cases:28.19%
controls:0.65%
cases:50.11%
controls:11.04%
cases:89.30%
controls:56.67%
cases:97.97%
controls:85.26%
358
3465
89
1000
338
2522
109
1943
199
499
248
3966
126
29
321
4436
220
493
219
3971
384
2501
46
1912
338
3153
7
545
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
5.0e-01
9.8e-01
4.9e+00
1.0e+50
3.4e+00
2.3e+00
1.0e+00
cases:6.49%
controls:4.05%
cases:5.82%
controls:2.26%
cases:23.49%
controls:0.22%
cases:3.36%
controls:0.00%
cases:6.38%
controls:0.22%
cases:15.35%
controls:1.81%
cases:16.52%
controls:6.52%
29
181
418
4284
26
101
421
4364
105
10
342
4455
15
0
432
4465
28
10
411
4454
66
80
364
4333
57
241
288
3457
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
4.7e-01
1.1e+00
5.2e+00
1.0e+50
3.3e+00
2.1e+00
9.9e-01
cases:8.95%
controls:5.78%
cases:7.83%
controls:2.87%
cases:28.19%
controls:0.22%
cases:4.03%
controls:0.00%
cases:8.66%
controls:0.36%
cases:17.67%
controls:2.52%
cases:20.29%
controls:8.65%
40
258
407
4207
35
128
412
4337
126
10
321
4455
18
0
429
4465
38
16
401
4448
76
111
354
4302
70
320
275
3378
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
2.2e-01
1.5e+00
3.5e+00
1.0e+50
3.4e+00
2.3e+00
1.8e+00
cases:13.20%
controls:10.91%
cases:23.04%
controls:6.02%
cases:24.38%
controls:0.94%
cases:2.46%
controls:0.00%
cases:18.68%
controls:0.76%
cases:39.30%
controls:5.96%
cases:56.23%
controls:18.23%
59
487
388
3978
103
269
344
4196
109
42
338
4423
11
0
436
4465
82
34
357
4430
169
263
261
4150
194
674
151
3024
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
1.2e-01
1.5e+00
4.3e+00
1.0e+50
3.7e+00
1.9e+00
1.1e+00
cases:6.04%
controls:5.40%
cases:11.41%
controls:2.75%
cases:18.34%
controls:0.31%
cases:2.91%
controls:0.00%
cases:11.85%
controls:0.34%
cases:15.58%
controls:2.72%
cases:23.19%
controls:8.73%
27
241
420
4224
51
123
396
4342
82
14
365
4451
13
0
434
4465
52
15
387
4449
67
120
363
4293
80
323
265
3375
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1.4e-01
1.3e+00
3.5e+00
—
3.6e+00
2.0e+00
1.4e+00
cases:10.96%
controls:9.70%
cases:17.23%
controls:5.26%
cases:23.27%
controls:0.90%
—
—
cases:23.92%
controls:0.85%
cases:31.63%
controls:5.67%
cases:44.35%
controls:16.41%
49
433
398
4032
77
235
370
4230
104
40
343
4425
—
105
38
334
4426
136
250
294
4163
153
607
192
3091
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
1.4e-01
1.2e+00
4.7e+00
1.0e+50
3.1e+00
1.9e+00
8.4e-01
cases:9.84%
controls:8.69%
cases:12.53%
controls:3.96%
cases:34.00%
controls:0.45%
cases:3.80%
controls:0.00%
cases:8.88%
controls:0.45%
cases:20.00%
controls:3.56%
cases:25.80%
controls:13.03%
44
388
403
4077
56
177
391
4288
152
20
295
4445
17
0
430
4465
39
20
400
4444
86
157
344
4256
89
482
256
3216
Gastroenterology
10 [38004455]
6.3e-01
2.3e+00
3.3e+00
—
3.0e+00
1.5e+00
9.8e-01
cases:10.07%
controls:5.62%
cases:18.34%
controls:2.11%
cases:8.72%
controls:0.36%
—
—
cases:7.06%
controls:0.36%
cases:9.53%
controls:2.27%
cases:16.23%
controls:6.79%
45
251
402
4214
82
94
365
4371
39
16
408
4449
—
31
16
408
4448
41
100
389
4313
56
251
289
3447
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
4.1e-01
2.2e+00
4.5e+00
1.0e+50
—
3.0e+00
1.9e+00
cases:2.24%
controls:1.50%
cases:5.82%
controls:0.69%
cases:14.09%
controls:0.18%
cases:1.12%
controls:0.00%
—
—
cases:11.40%
controls:0.63%
cases:11.59%
controls:1.97%
10
67
437
4398
26
31
421
4434
63
8
384
4457
5
0
442
4465
—
49
28
381
4385
40
73
305
3625
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
3.3e-02
7.4e-01
2.5e+00
3.8e+00
2.9e+00
9.9e-01
7.5e-01
cases:35.57%
controls:34.83%
cases:40.27%
controls:24.28%
cases:31.54%
controls:3.78%
cases:7.16%
controls:0.18%
cases:41.23%
controls:3.88%
cases:46.74%
controls:24.65%
cases:70.43%
controls:52.89%
159
1555
288
2910
180
1084
267
3381
141
169
306
4296
32
8
415
4457
181
173
258
4291
201
1088
229
3325
243
1956
102
1742
INR in Blood by Coagulation assay
34714-6 [3032080]
6.2e-02
1.0e+00
2.7e+00
3.7e+00
1.9e+00
1.3e+00
8.9e-01
cases:13.87%
controls:13.15%
cases:21.48%
controls:8.76%
cases:31.54%
controls:3.07%
cases:5.15%
controls:0.13%
cases:17.77%
controls:3.05%
cases:24.88%
controls:8.20%
cases:37.10%
controls:19.50%
62
587
385
3878
96
391
351
4074
141
137
306
4328
23
6
424
4459
78
136
361
4328
107
362
323
4051
128
721
217
2977
Medical doctor
Z2221 [2001311556]
3.8e-01
1.6e+00
3.3e+00
—
2.8e+00
1.9e+00
1.4e+00
cases:7.16%
controls:5.02%
cases:6.26%
controls:1.37%
cases:4.25%
controls:0.16%
—
—
cases:2.96%
controls:0.18%
cases:4.65%
controls:0.70%
cases:6.38%
controls:1.62%
32
224
415
4241
28
61
419
4404
19
7
428
4458
—
13
8
426
4456
20
31
410
4382
22
60
323
3638
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
3.9e-01
1.8e+00
—
—
3.4e+00
3.6e+00
2.1e+00
cases:2.91%
controls:1.99%
cases:4.25%
controls:0.76%
—
—
—
—
cases:3.42%
controls:0.11%
cases:17.91%
controls:0.59%
cases:15.94%
controls:2.16%
13
89
434
4376
19
34
428
4431
—
—
15
5
424
4459
77
26
353
4387
55
80
290
3618
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
1.9e-01
7.3e-01
2.4e+00
3.5e+00
2.5e+00
1.0e+00
7.3e-01
cases:32.66%
controls:28.56%
cases:40.72%
controls:24.79%
cases:35.12%
controls:4.61%
cases:4.47%
controls:0.13%
cases:35.99%
controls:4.50%
cases:51.16%
controls:27.01%
cases:70.43%
controls:53.41%
146
1275
301
3190
182
1107
265
3358
157
206
290
4259
20
6
427
4459
158
201
281
4263
220
1192
210
3221
243
1975
102
1723
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
6.1e-02
5.4e-01
2.5e+00
4.2e+00
2.5e+00
8.2e-01
4.6e-01
cases:43.85%
controls:42.35%
cases:48.55%
controls:35.52%
cases:46.09%
controls:6.61%
cases:14.77%
controls:0.27%
cases:45.56%
controls:6.61%
cases:57.91%
controls:37.75%
cases:74.78%
controls:65.22%
196
1891
251
2574
217
1586
230
2879
206
295
241
4170
66
12
381
4453
200
295
239
4169
249
1666
181
2747
258
2412
87
1286
Outpatient Hospital
22 [8756]
2.3e-01
1.0e+00
4.2e+00
—
3.2e+00
1.6e+00
8.6e-01
cases:30.43%
controls:25.76%
cases:17.45%
controls:7.12%
cases:27.07%
controls:0.54%
—
—
cases:17.08%
controls:0.83%
cases:21.63%
controls:5.35%
cases:27.83%
controls:14.01%
136
1150
311
3315
78
318
369
4147
121
24
326
4441
—
75
37
364
4427
93
236
337
4177
96
518
249
3180
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
6.9e-02
5.1e-01
2.5e+00
4.2e+00
2.4e+00
7.9e-01
4.5e-01
cases:44.30%
controls:42.60%
cases:48.55%
controls:36.17%
cases:46.31%
controls:6.72%
cases:13.87%
controls:0.25%
cases:45.56%
controls:6.74%
cases:57.91%
controls:38.41%
cases:74.78%
controls:65.44%
198
1902
249
2563
217
1615
230
2850
207
300
240
4165
62
11
385
4454
200
301
239
4163
249
1695
181
2718
258
2420
87
1278
Extensive abdominal CT
JN3BD [2001305556]
8.0e-01
2.8e+00
1.0e+50
1.0e+50
1.0e+50
4.2e+00
3.8e+00
cases:3.13%
controls:1.43%
cases:4.47%
controls:0.29%
cases:4.25%
controls:0.00%
cases:1.34%
controls:0.00%
cases:2.51%
controls:0.00%
cases:14.65%
controls:0.25%
cases:21.16%
controls:0.59%
14
64
433
4401
20
13
427
4452
19
0
428
4465
6
0
441
4465
11
0
428
4464
63
11
367
4402
73
22
272
3676
One hour or less
ZXE00 [2001311394]
5.6e-01
1.1e+00
3.5e+00
—
3.0e+00
1.8e+00
1.3e+00
cases:10.29%
controls:6.16%
cases:4.92%
controls:1.68%
cases:4.25%
controls:0.13%
—
—
cases:2.28%
controls:0.11%
cases:5.81%
controls:1.00%
cases:10.43%
controls:3.00%
46
275
401
4190
22
75
425
4390
19
6
428
4459
—
10
5
429
4459
25
44
405
4369
36
111
309
3587
Treatment plan or consultation
WZC00 [2001310885]
5.8e-01
1.1e+00
2.4e+00
—
3.3e+00
2.1e+00
1.5e+00
cases:7.83%
controls:4.55%
cases:4.92%
controls:1.63%
cases:2.01%
controls:0.18%
—
—
cases:4.78%
controls:0.18%
cases:12.09%
controls:1.68%
cases:21.74%
controls:5.95%
35
203
412
4262
22
73
425
4392
9
8
438
4457
—
21
8
418
4456
52
74
378
4339
75
220
270
3478
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
4.2e-02
5.6e-01
2.5e+00
4.3e+00
2.3e+00
7.7e-01
3.3e-01
cases:48.77%
controls:47.73%
cases:55.03%
controls:41.10%
cases:51.45%
controls:8.31%
cases:20.13%
controls:0.34%
cases:48.97%
controls:8.60%
cases:63.02%
controls:44.07%
cases:77.68%
controls:71.50%
218
2131
229
2334
246
1835
201
2630
230
371
217
4094
90
15
357
4450
215
384
224
4080
271
1945
159
2468
268
2644
77
1054
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
8.1e-02
6.3e-01
2.5e+00
3.5e+00
2.4e+00
8.7e-01
5.1e-01
cases:46.98%
controls:44.97%
cases:54.59%
controls:39.10%
cases:48.99%
controls:7.55%
cases:8.72%
controls:0.29%
cases:46.47%
controls:7.64%
cases:63.02%
controls:41.69%
cases:78.84%
controls:69.15%
210
2008
237
2457
244
1746
203
2719
219
337
228
4128
39
13
408
4452
204
341
235
4123
271
1840
159
2573
272
2557
73
1141
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
4.1e-02
5.6e-01
2.5e+00
4.2e+00
2.3e+00
7.8e-01
3.3e-01
cases:48.77%
controls:47.75%
cases:55.03%
controls:41.14%
cases:51.45%
controls:8.35%
cases:17.67%
controls:0.34%
cases:48.97%
controls:8.60%
cases:63.26%
controls:44.16%
cases:77.68%
controls:71.53%
218
2132
229
2333
246
1837
201
2628
230
373
217
4092
79
15
368
4450
215
384
224
4080
272
1949
158
2464
268
2645
77
1053
MCH [Entitic mass]
28539-5 [3035941]
4.4e-02
5.7e-01
2.5e+00
4.1e+00
2.3e+00
7.8e-01
3.3e-01
cases:48.77%
controls:47.66%
cases:55.03%
controls:40.96%
cases:51.45%
controls:8.29%
cases:17.00%
controls:0.34%
cases:48.97%
controls:8.60%
cases:63.02%
controls:43.87%
cases:77.68%
controls:71.47%
218
2128
229
2337
246
1829
201
2636
230
370
217
4095
76
15
371
4450
215
384
224
4080
271
1936
159
2477
268
2643
77
1055
Leukocytes [#/volume] in Blood
26464-8 [3010813]
4.1e-02
5.7e-01
2.5e+00
4.1e+00
2.3e+00
7.7e-01
3.2e-01
cases:48.77%
controls:47.75%
cases:55.26%
controls:41.12%
cases:51.68%
controls:8.33%
cases:17.00%
controls:0.34%
cases:48.97%
controls:8.62%
cases:63.02%
controls:44.05%
cases:77.68%
controls:71.55%
218
2132
229
2333
247
1836
200
2629
231
372
216
4093
76
15
371
4450
215
385
224
4079
271
1944
159
2469
268
2646
77
1052
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
4.3e-02
5.6e-01
2.5e+00
4.1e+00
2.3e+00
7.8e-01
3.3e-01
cases:48.77%
controls:47.70%
cases:55.03%
controls:41.03%
cases:51.45%
controls:8.31%
cases:17.00%
controls:0.34%
cases:48.97%
controls:8.60%
cases:63.02%
controls:43.94%
cases:77.68%
controls:71.53%
218
2130
229
2335
246
1832
201
2633
230
371
217
4094
76
15
371
4450
215
384
224
4080
271
1939
159
2474
268
2645
77
1053
Platelets [#/volume] in Blood
26515-7 [3007461]
3.6e-02
5.7e-01
2.5e+00
4.1e+00
2.3e+00
7.8e-01
3.3e-01
cases:48.55%
controls:47.66%
cases:55.03%
controls:41.01%
cases:51.45%
controls:8.33%
cases:17.00%
controls:0.34%
cases:48.97%
controls:8.60%
cases:63.02%
controls:43.96%
cases:77.68%
controls:71.42%
217
2128
230
2337
246
1831
201
2634
230
372
217
4093
76
15
371
4450
215
384
224
4080
271
1940
159
2473
268
2641
77
1057
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
4.2e-02
5.6e-01
2.5e+00
4.1e+00
2.3e+00
7.7e-01
3.3e-01
cases:48.77%
controls:47.73%
cases:55.03%
controls:41.05%
cases:51.45%
controls:8.33%
cases:17.00%
controls:0.34%
cases:48.97%
controls:8.60%
cases:63.02%
controls:44.07%
cases:77.68%
controls:71.53%
218
2131
229
2334
246
1833
201
2632
230
372
217
4093
76
15
371
4450
215
384
224
4080
271
1945
159
2468
268
2645
77
1053
Benign neoplasm: Stomach
D13.1 [45586087]
2.0e+00
4.1e+00
1.0e+50
1.0e+50
—
—
4.1e+00
cases:1.57%
controls:0.22%
cases:7.61%
controls:0.13%
cases:7.83%
controls:0.00%
cases:6.26%
controls:0.00%
—
—
—
—
cases:10.72%
controls:0.19%
7
10
440
4455
34
6
413
4459
35
0
412
4465
28
0
419
4465
—
—
37
7
308
3691
Inpatient Hospital
21 [8717]
1.6e-01
1.0e+00
3.6e+00
—
3.4e+00
1.3e+00
8.3e-01
cases:34.90%
controls:31.38%
cases:23.71%
controls:9.90%
cases:28.41%
controls:1.05%
—
—
cases:22.78%
controls:1.01%
cases:24.65%
controls:8.02%
cases:33.33%
controls:17.93%
156
1401
291
3064
106
442
341
4023
127
47
320
4418
—
100
45
339
4419
106
354
324
4059
115
663
230
3035
Supplier / Service Provider
OMOP5117446 [33004]
-6.6e-01
2.9e-01
1.8e+00
—
3.3e+00
3.0e+00
2.7e+00
cases:14.32%
controls:24.39%
cases:10.51%
controls:8.09%
cases:4.92%
controls:0.87%
—
—
cases:4.10%
controls:0.16%
cases:13.02%
controls:0.75%
cases:21.74%
controls:1.76%
64
1089
383
3376
47
361
400
4104
22
39
425
4426
—
18
7
421
4457
56
33
374
4380
75
65
270
3633
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
2.1e-01
1.2e+00
4.0e+00
1.0e+50
2.8e+00
1.3e+00
6.6e-01
cases:7.83%
controls:6.47%
cases:10.96%
controls:3.47%
cases:10.96%
controls:0.22%
cases:1.57%
controls:0.00%
cases:5.69%
controls:0.36%
cases:11.16%
controls:3.22%
cases:19.42%
controls:11.06%
35
289
412
4176
49
155
398
4310
49
10
398
4455
7
0
440
4465
25
16
414
4448
48
142
382
4271
67
409
278
3289
Office Visit
OMOP4822458 [581477]
1.4e-02
9.4e-01
3.5e+00
—
3.1e+00
1.5e+00
9.8e-01
cases:8.05%
controls:7.95%
cases:6.04%
controls:2.44%
cases:4.92%
controls:0.16%
—
—
cases:5.01%
controls:0.25%
cases:7.67%
controls:1.74%
cases:11.88%
controls:4.81%
36
355
411
4110
27
109
420
4356
22
7
425
4458
—
22
11
417
4453
33
77
397
4336
41
178
304
3520
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
2.9e-01
1.1e+00
2.9e+00
—
2.7e+00
1.8e+00
1.4e+00
cases:26.40%
controls:21.19%
cases:32.21%
controls:13.17%
cases:27.52%
controls:2.08%
—
—
cases:21.18%
controls:1.75%
cases:47.21%
controls:13.37%
cases:66.96%
controls:32.94%
118
946
329
3519
144
588
303
3877
123
93
324
4372
—
93
78
346
4386
203
590
227
3823
231
1218
114
2480
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
8.4e-02
5.8e-01
2.3e+00
4.0e+00
2.2e+00
7.8e-01
3.1e-01
cases:28.19%
controls:26.52%
cases:34.90%
controls:23.07%
cases:33.33%
controls:4.97%
cases:9.62%
controls:0.20%
cases:32.57%
controls:5.31%
cases:42.33%
controls:25.20%
cases:55.36%
controls:47.67%
126
1184
321
3281
156
1030
291
3435
149
222
298
4243
43
9
404
4456
143
237
296
4227
182
1112
248
3301
191
1763
154
1935
CBC panel - Blood by Automated count
58410-2 [40761511]
9.3e-02
5.8e-01
2.4e+00
3.8e+00
2.3e+00
6.0e-01
1.6e-01
cases:42.51%
controls:40.25%
cases:41.83%
controls:28.62%
cases:36.24%
controls:4.75%
cases:12.53%
controls:0.31%
cases:33.71%
controls:4.93%
cases:41.86%
controls:28.37%
cases:59.42%
controls:55.49%
190
1797
257
2668
187
1278
260
3187
162
212
285
4253
56
14
391
4451
148
220
291
4244
180
1252
250
3161
205
2052
140
1646
General Surgery
2 [38004447]
9.0e-02
1.2e+00
3.2e+00
1.0e+50
3.1e+00
1.5e+00
7.2e-01
cases:17.45%
controls:16.19%
cases:10.96%
controls:3.56%
cases:10.51%
controls:0.47%
cases:2.01%
controls:0.00%
cases:9.11%
controls:0.45%
cases:14.19%
controls:3.72%
cases:19.71%
controls:10.63%
78
723
369
3742
49
159
398
4306
47
21
400
4444
9
0
438
4465
40
20
399
4444
61
164
369
4249
68
393
277
3305
Physiotherapy
R4110 [2001310233]
1.4e-01
6.5e-01
4.6e+00
1.0e+50
2.5e+00
1.8e+00
7.9e-01
cases:5.82%
controls:5.11%
cases:3.58%
controls:1.90%
cases:9.62%
controls:0.11%
cases:5.15%
controls:0.00%
cases:3.19%
controls:0.27%
cases:8.84%
controls:1.61%
cases:11.01%
controls:5.33%
26
228
421
4237
16
85
431
4380
43
5
404
4460
23
0
424
4465
14
12
425
4452
38
71
392
4342
38
197
307
3501
Laboratory Visit
OMOP4822461 [32036]
8.7e-02
4.2e-01
1.9e+00
4.8e+00
1.9e+00
5.3e-01
2.4e-01
cases:53.69%
controls:51.53%
cases:60.18%
controls:49.90%
cases:55.26%
controls:15.21%
cases:48.99%
controls:0.78%
cases:53.99%
controls:14.72%
cases:66.51%
controls:53.77%
cases:79.71%
controls:75.64%
240
2301
207
2164
269
2228
178
2237
247
679
200
3786
219
35
228
4430
237
657
202
3807
286
2373
144
2040
275
2797
70
901
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
-1.2e-01
1.2e+00
2.9e+00
—
3.0e+00
1.6e+00
9.7e-01
cases:6.26%
controls:7.03%
cases:10.29%
controls:3.49%
cases:9.62%
controls:0.58%
—
—
cases:7.06%
controls:0.38%
cases:14.65%
controls:3.47%
cases:25.80%
controls:11.68%
28
314
419
4151
46
156
401
4309
43
26
404
4439
—
31
17
408
4447
63
153
367
4260
89
432
256
3266
Cancer Ag 19-9 [Units/volume] in Serum or Plasma
24108-3 [3022914]
—
3.3e+00
—
—
—
3.8e+00
2.1e+00
—
—
cases:6.94%
controls:0.27%
—
—
—
—
—
—
cases:8.37%
controls:0.20%
cases:5.51%
controls:0.68%
—
31
12
416
4453
—
—
—
36
9
394
4404
19
25
326
3673
Tissue Pathology biopsy report
66121-5 [40768804]
2.7e-01
1.3e+00
2.6e+00
—
2.5e+00
1.8e+00
1.0e+00
cases:9.17%
controls:7.14%
cases:9.62%
controls:2.82%
cases:3.36%
controls:0.25%
—
—
cases:3.19%
controls:0.27%
cases:12.09%
controls:2.29%
cases:21.45%
controls:8.84%
41
319
406
4146
43
126
404
4339
15
11
432
4454
—
14
12
425
4452
52
101
378
4312
74
327
271
3371
Body CT examination
JN4AD [2001310897]
1.2e+00
3.0e+00
—
—
—
3.3e+00
2.9e+00
cases:1.57%
controls:0.47%
cases:3.36%
controls:0.18%
—
—
—
—
—
—
cases:7.91%
controls:0.32%
cases:19.13%
controls:1.24%
7
21
440
4444
15
8
432
4457
—
—
—
34
14
396
4399
66
46
279
3652
Abdominal CT examination both without and with contrast
JN3CD [2001305561]
2.0e+00
—
—
—
—
3.3e+00
3.9e+00
cases:1.79%
controls:0.25%
—
—
—
—
—
—
—
—
cases:3.02%
controls:0.11%
cases:6.09%
controls:0.14%
8
11
439
4454
—
—
—
—
13
5
417
4408
21
5
324
3693
Immunohistochemistry procedure
117617002 [4035726]
1.2e+00
2.8e+00
—
1.0e+50
—
3.7e+00
2.7e+00
cases:1.34%
controls:0.40%
cases:3.80%
controls:0.25%
—
—
cases:33.33%
controls:0.00%
—
—
cases:5.81%
controls:0.16%
cases:5.51%
controls:0.41%
6
18
441
4447
17
11
430
4454
—
149
0
298
4465
—
25
7
405
4406
19
15
326
3683
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2039-6 [3003785]
9.5e-01
3.1e+00
—
1.0e+50
—
3.5e+00
2.5e+00
cases:2.24%
controls:0.87%
cases:11.41%
controls:0.60%
—
—
cases:1.79%
controls:0.00%
—
—
cases:14.19%
controls:0.52%
cases:15.65%
controls:1.43%
10
39
437
4426
51
27
396
4438
—
8
0
439
4465
—
61
23
369
4390
54
53
291
3645
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
5.3e-01
1.0e+00
—
—
4.2e+00
2.7e+00
2.1e+00
cases:4.92%
controls:2.96%
cases:3.13%
controls:1.16%
—
—
—
—
cases:9.11%
controls:0.16%
cases:16.74%
controls:1.31%
cases:26.09%
controls:4.25%
22
132
425
4333
14
52
433
4413
—
—
40
7
399
4457
72
58
358
4355
90
157
255
3541
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
-1.9e-02
7.3e-01
3.5e+00
1.0e+50
2.7e+00
1.2e+00
7.2e-01
cases:14.32%
controls:14.56%
cases:15.21%
controls:7.97%
cases:21.48%
controls:0.85%
cases:7.38%
controls:0.00%
cases:13.90%
controls:1.03%
cases:21.63%
controls:7.84%
cases:40.00%
controls:24.58%
64
650
383
3815
68
356
379
4109
96
38
351
4427
33
0
414
4465
61
46
378
4418
93
346
337
4067
138
909
207
2789
Short blood count panel - Blood
55429-5 [40758558]
3.4e-01
1.1e+00
2.2e+00
—
2.4e+00
1.9e+00
1.2e+00
cases:7.16%
controls:5.22%
cases:8.28%
controls:3.05%
cases:4.25%
controls:0.49%
—
—
cases:5.47%
controls:0.54%
cases:16.05%
controls:2.65%
cases:25.80%
controls:9.09%
32
233
415
4232
37
136
410
4329
19
22
428
4443
—
24
24
415
4440
69
117
361
4296
89
336
256
3362
Bacteria identified in Blood by Culture
600-7 [3023368]
-1.3e-01
7.9e-01
2.6e+00
1.0e+50
3.3e+00
1.4e+00
7.7e-01
cases:4.70%
controls:5.33%
cases:5.59%
controls:2.62%
cases:3.36%
controls:0.27%
cases:1.12%
controls:0.00%
cases:7.29%
controls:0.29%
cases:9.07%
controls:2.45%
cases:17.97%
controls:9.22%
21
238
426
4227
25
117
422
4348
15
12
432
4453
5
0
442
4465
32
13
407
4451
39
108
391
4305
62
341
283
3357
Other and unspecified abdominal pain
R10.4 [45568113]
-6.8e-02
1.1e+00
3.3e+00
—
2.2e+00
1.3e+00
8.8e-01
cases:5.15%
controls:5.49%
cases:5.59%
controls:1.97%
cases:4.47%
controls:0.18%
—
—
cases:2.28%
controls:0.25%
cases:5.58%
controls:1.56%
cases:11.88%
controls:5.27%
23
245
424
4220
25
88
422
4377
20
8
427
4457
—
10
11
429
4453
24
69
406
4344
41
195
304
3503
Scheduled procedure
ZXD10 [2001311387]
3.0e-01
1.2e+00
4.1e+00
—
—
2.0e+00
1.4e+00
cases:8.72%
controls:6.63%
cases:4.92%
controls:1.59%
cases:6.26%
controls:0.11%
—
—
—
—
cases:6.74%
controls:1.00%
cases:9.57%
controls:2.49%
39
296
408
4169
22
71
425
4394
28
5
419
4460
—
—
29
44
401
4369
33
92
312
3606
Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
83084-4 [42529201]
—
2.9e+00
1.0e+50
1.0e+50
—
3.0e+00
2.7e+00
—
—
cases:2.01%
controls:0.11%
cases:2.01%
controls:0.00%
cases:1.12%
controls:0.00%
—
—
cases:3.49%
controls:0.18%
cases:4.06%
controls:0.27%
—
9
5
438
4460
9
0
438
4465
5
0
442
4465
—
15
8
415
4405
14
10
331
3688
Thorax X-ray examination
GD1AA [2001303617]
4.1e-01
1.1e+00
2.8e+00
1.0e+50
2.4e+00
1.3e+00
8.0e-01
cases:15.21%
controls:10.64%
cases:10.96%
controls:3.90%
cases:7.38%
controls:0.49%
cases:1.57%
controls:0.00%
cases:5.24%
controls:0.49%
cases:12.56%
controls:3.67%
cases:22.90%
controls:11.76%
68
475
379
3990
49
174
398
4291
33
22
414
4443
7
0
440
4465
23
22
416
4442
54
162
376
4251
79
435
266
3263
ABO and Rh group [Type] in Blood
882-1 [3003694]
3.6e-02
1.7e+00
4.3e+00
—
2.3e+00
6.2e-01
-7.2e-02
cases:4.47%
controls:4.32%
cases:6.71%
controls:1.28%
cases:9.40%
controls:0.13%
—
—
cases:1.14%
controls:0.11%
cases:2.33%
controls:1.27%
cases:5.51%
controls:5.90%
20
193
427
4272
30
57
417
4408
42
6
405
4459
—
5
5
434
4459
10
56
420
4357
19
218
326
3480
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
7.2e-02
6.1e-01
2.3e+00
1.0e+50
2.5e+00
1.7e+00
1.3e+00
cases:10.96%
controls:10.28%
cases:9.40%
controls:5.35%
cases:6.04%
controls:0.67%
cases:7.38%
controls:0.00%
cases:9.34%
controls:0.81%
cases:24.88%
controls:5.94%
cases:43.77%
controls:17.50%
49
459
398
4006
42
239
405
4226
27
30
420
4435
33
0
414
4465
41
36
398
4428
107
262
323
4151
151
647
194
3051
Nutritional therapy
R4190 [2001310243]
—
2.5e+00
—
—
1.0e+50
3.7e+00
2.0e+00
—
—
cases:1.57%
controls:0.13%
—
—
—
—
cases:1.37%
controls:0.00%
cases:4.42%
controls:0.11%
cases:1.74%
controls:0.24%
—
7
6
440
4459
—
—
6
0
433
4464
19
5
411
4408
6
9
339
3689
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
1.9e-01
9.3e-01
2.1e+00
—
2.1e+00
1.8e+00
1.3e+00
cases:15.44%
controls:13.10%
cases:18.34%
controls:8.11%
cases:11.86%
controls:1.68%
—
—
cases:12.30%
controls:1.75%
cases:34.42%
controls:8.32%
cases:50.43%
controls:21.25%
69
585
378
3880
82
362
365
4103
53
75
394
4390
—
54
78
385
4386
148
367
282
4046
174
786
171
2912
Emergency Room Visit
ER [9203]
1.6e-01
1.0e+00
3.1e+00
1.0e+50
2.2e+00
8.7e-01
6.9e-01
cases:41.16%
controls:37.40%
cases:28.19%
controls:12.43%
cases:19.24%
controls:1.08%
cases:2.01%
controls:0.00%
cases:11.16%
controls:1.32%
cases:22.56%
controls:10.88%
cases:44.06%
controls:28.31%
184
1670
263
2795
126
555
321
3910
86
48
361
4417
9
0
438
4465
49
59
390
4405
97
480
333
3933
152
1047
193
2651
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
-1.8e-01
2.8e-01
2.0e+00
3.5e+00
2.0e+00
4.2e-01
-1.2e-02
cases:31.32%
controls:35.32%
cases:34.68%
controls:28.53%
cases:31.10%
controls:5.91%
cases:9.40%
controls:0.31%
cases:32.35%
controls:6.14%
cases:40.00%
controls:30.55%
cases:53.04%
controls:53.35%
140
1577
307
2888
155
1274
292
3191
139
264
308
4201
42
14
405
4451
142
274
297
4190
172
1348
258
3065
183
1973
162
1725
Inpatient Visit
IP [9201]
1.4e-01
4.8e-01
2.5e+00
—
2.9e+00
1.7e+00
7.0e-01
cases:6.04%
controls:5.29%
cases:4.03%
controls:2.53%
cases:5.37%
controls:0.45%
—
—
cases:4.78%
controls:0.27%
cases:14.42%
controls:3.06%
cases:20.29%
controls:11.22%
27
236
420
4229
18
113
429
4352
24
20
423
4445
—
21
12
418
4452
62
135
368
4278
70
415
275
3283
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
4.0e-01
8.3e-01
1.4e+00
—
3.1e+00
1.5e+00
9.0e-01
cases:11.63%
controls:8.09%
cases:6.49%
controls:2.93%
cases:2.46%
controls:0.63%
—
—
cases:10.71%
controls:0.54%
cases:10.70%
controls:2.65%
cases:15.07%
controls:6.73%
52
361
395
4104
29
131
418
4334
11
28
436
4437
—
47
24
392
4440
46
117
384
4296
52
249
293
3449
Stomach Pathology biopsy report
66114-0 [40768797]
7.0e-01
3.0e+00
—
1.0e+50
2.5e+00
1.2e+00
9.3e-01
cases:5.59%
controls:2.87%
cases:18.34%
controls:1.12%
—
—
cases:5.37%
controls:0.00%
cases:1.59%
controls:0.13%
cases:3.26%
controls:0.97%
cases:8.99%
controls:3.76%
25
128
422
4337
82
50
365
4415
—
24
0
423
4465
7
6
432
4458
14
43
416
4370
31
139
314
3559
pH of Serum or Plasma
2753-2 [3018418]
2.2e-01
6.9e-01
2.1e+00
—
2.5e+00
1.7e+00
1.3e+00
cases:7.38%
controls:6.02%
cases:5.59%
controls:2.89%
cases:2.91%
controls:0.36%
—
—
cases:4.33%
controls:0.38%
cases:17.44%
controls:3.63%
cases:31.30%
controls:11.55%
33
269
414
4196
25
129
422
4336
13
16
434
4449
—
19
17
420
4447
75
160
355
4253
108
427
237
3271
Urgent procedure
ZXD05 [2001311386]
4.1e-03
1.2e+00
3.9e+00
—
2.3e+00
1.1e+00
4.1e-01
cases:4.47%
controls:4.46%
cases:3.13%
controls:0.96%
cases:5.15%
controls:0.11%
—
—
cases:1.59%
controls:0.16%
cases:2.56%
controls:0.84%
cases:3.77%
controls:2.54%
20
199
427
4266
14
43
433
4422
23
5
424
4460
—
7
7
432
4457
11
37
419
4376
13
94
332
3604
Essential (primary) hypertension
I10 [45591453]
1.8e-01
4.3e-01
1.7e+00
3.9e+00
1.5e+00
2.9e-01
7.5e-02
cases:29.98%
controls:26.36%
cases:18.57%
controls:12.97%
cases:9.84%
controls:1.90%
cases:5.37%
controls:0.11%
cases:8.66%
controls:2.04%
cases:19.53%
controls:15.39%
cases:35.36%
controls:33.67%
134
1177
313
3288
83
579
364
3886
44
85
403
4380
24
5
423
4460
38
91
401
4373
84
679
346
3734
122
1245
223
2453
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
-6.7e-02
1.2e+00
2.4e+00
—
1.9e+00
9.2e-01
7.3e-01
cases:5.59%
controls:5.96%
cases:8.72%
controls:2.71%
cases:4.70%
controls:0.45%
—
—
cases:1.59%
controls:0.25%
cases:7.44%
controls:3.10%
cases:17.68%
controls:9.38%
25
266
422
4199
39
121
408
4344
21
20
426
4445
—
7
11
432
4453
32
137
398
4276
61
347
284
3351
loperamide oxide; oral
A07DA05 [21600648]
9.5e-01
1.1e+00
—
—
2.8e+00
2.9e+00
1.5e+00
cases:2.68%
controls:1.05%
cases:1.79%
controls:0.58%
—
—
—
—
cases:1.82%
controls:0.11%
cases:9.30%
controls:0.59%
cases:6.09%
controls:1.46%
12
47
435
4418
8
26
439
4439
—
—
8
5
431
4459
40
26
390
4387
21
54
324
3644
loperamide; oral
A07DA03 [21600646]
9.5e-01
1.1e+00
—
—
2.8e+00
2.9e+00
1.5e+00
cases:2.68%
controls:1.05%
cases:1.79%
controls:0.58%
—
—
—
—
cases:1.82%
controls:0.11%
cases:9.30%
controls:0.59%
cases:6.09%
controls:1.46%
12
47
435
4418
8
26
439
4439
—
—
8
5
431
4459
40
26
390
4387
21
54
324
3644
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
4.8e-01
8.0e-01
1.5e+00
—
3.2e+00
2.3e+00
1.7e+00
cases:4.03%
controls:2.53%
cases:3.13%
controls:1.43%
cases:1.57%
controls:0.36%
—
—
cases:7.97%
controls:0.36%
cases:15.35%
controls:1.84%
cases:21.16%
controls:4.84%
18
113
429
4352
14
64
433
4401
7
16
440
4449
—
35
16
404
4448
66
81
364
4332
73
179
272
3519
Extensive body CT
JN4BD [2001310899]
6.6e-01
3.2e+00
—
—
1.0e+50
—
3.8e+00
cases:1.12%
controls:0.58%
cases:4.92%
controls:0.20%
—
—
—
—
cases:2.51%
controls:0.00%
—
—
cases:16.52%
controls:0.43%
5
26
442
4439
22
9
425
4456
—
—
11
0
428
4464
—
57
16
288
3682
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
-1.1e-01
5.0e-01
2.1e+00
—
2.3e+00
1.5e+00
1.2e+00
cases:10.51%
controls:11.60%
cases:9.84%
controls:6.23%
cases:6.04%
controls:0.81%
—
—
cases:8.88%
controls:0.96%
cases:25.12%
controls:7.07%
cases:45.22%
controls:20.61%
47
518
400
3947
44
278
403
4187
27
36
420
4429
—
39
43
400
4421
108
312
322
4101
156
762
189
2936
pantoprazole; oral, parenteral
A02BC02 [21600097]
1.9e-01
9.2e-01
1.4e+00
1.8e+00
2.3e+00
1.4e+00
8.9e-01
cases:24.61%
controls:21.28%
cases:26.40%
controls:12.54%
cases:11.63%
controls:3.02%
cases:1.34%
controls:0.22%
cases:21.18%
controls:2.69%
cases:38.60%
controls:13.10%
cases:44.06%
controls:24.45%
110
950
337
3515
118
560
329
3905
52
135
395
4330
6
10
441
4455
93
120
346
4344
166
578
264
3835
152
904
193
2794
Normoblasts [#/volume] in Blood
715-3 [3021589]
3.4e-01
7.8e-01
2.4e+00
—
1.8e+00
1.1e+00
8.7e-01
cases:12.08%
controls:8.91%
cases:14.77%
controls:7.35%
cases:12.08%
controls:1.25%
—
—
cases:9.11%
controls:1.61%
cases:20.93%
controls:8.25%
cases:35.94%
controls:18.98%
54
398
393
4067
66
328
381
4137
54
56
393
4409
—
40
72
399
4392
90
364
340
4049
124
702
221
2996
Abdominal CT examination
JN3AD [2001305554]
4.5e-01
2.2e+00
—
1.0e+50
—
2.4e+00
2.3e+00
cases:1.12%
controls:0.72%
cases:2.68%
controls:0.31%
—
—
cases:1.34%
controls:0.00%
—
—
cases:5.12%
controls:0.48%
cases:19.42%
controls:2.46%
5
32
442
4433
12
14
435
4451
—
6
0
441
4465
—
22
21
408
4392
67
91
278
3607
Bacteria [Presence] in Urine
87829-8 [36304419]
4.0e-02
8.1e-01
2.3e+00
—
2.1e+00
9.8e-01
6.5e-01
cases:5.82%
controls:5.60%
cases:5.82%
controls:2.67%
cases:3.13%
controls:0.34%
—
—
cases:3.19%
controls:0.40%
cases:7.67%
controls:3.01%
cases:17.97%
controls:10.28%
26
250
421
4215
26
119
421
4346
14
15
433
4450
—
14
18
425
4446
33
133
397
4280
62
380
283
3318
Cancer Ag 125 [Units/volume] in Serum or Plasma
10334-1 [3037551]
—
2.2e+00
—
—
1.0e+50
2.8e+00
1.7e+00
—
—
cases:2.68%
controls:0.31%
—
—
—
—
cases:1.14%
controls:0.00%
cases:3.02%
controls:0.18%
cases:3.48%
controls:0.62%
—
12
14
435
4451
—
—
5
0
434
4464
13
8
417
4405
12
23
333
3675
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
1.9e-01
7.8e-01
1.5e+00
—
2.9e+00
1.8e+00
1.3e+00
cases:8.28%
controls:6.94%
cases:6.04%
controls:2.87%
cases:1.34%
controls:0.29%
—
—
cases:5.92%
controls:0.36%
cases:17.67%
controls:3.51%
cases:31.30%
controls:10.84%
37
310
410
4155
27
128
420
4337
6
13
441
4452
—
26
16
413
4448
76
155
354
4258
108
401
237
3297
Diverticular disease of large intestine without perforation or abscess
K57.3 [45567316]
4.7e-01
1.3e+00
2.3e+00
—
2.2e+00
3.2e-01
8.0e-01
cases:5.59%
controls:3.56%
cases:3.13%
controls:0.90%
cases:1.57%
controls:0.16%
—
—
cases:1.59%
controls:0.18%
cases:1.86%
controls:1.36%
cases:8.12%
controls:3.81%
25
159
422
4306
14
40
433
4425
7
7
440
4458
—
7
8
432
4456
8
60
422
4353
28
141
317
3557
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
6.5e-02
8.1e-01
1.4e+00
—
2.7e+00
2.2e+00
1.6e+00
cases:1.79%
controls:1.68%
cases:2.24%
controls:1.01%
cases:1.12%
controls:0.29%
—
—
cases:4.33%
controls:0.29%
cases:9.07%
controls:1.07%
cases:13.62%
controls:3.14%
8
75
439
4390
10
45
437
4420
5
13
442
4452
—
19
13
420
4451
39
47
391
4366
47
116
298
3582
Medical Oncology
90 [38004507]
—
—
1.0e+50
1.0e+50
1.0e+50
—
6.5e+00
—
—
—
—
cases:5.59%
controls:0.00%
cases:2.01%
controls:0.00%
cases:18.45%
controls:0.00%
—
—
cases:53.04%
controls:0.16%
—
—
25
0
422
4465
9
0
438
4465
81
0
358
4464
—
183
6
162
3692
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
1.9e-01
1.0e+00
2.3e+00
—
1.5e+00
9.3e-01
7.2e-01
cases:9.40%
controls:7.91%
cases:12.98%
controls:5.11%
cases:8.05%
controls:0.87%
—
—
cases:2.73%
controls:0.60%
cases:13.72%
controls:5.91%
cases:28.41%
controls:16.22%
42
353
405
4112
58
228
389
4237
36
39
411
4426
—
12
27
427
4437
59
261
371
4152
98
600
247
3098
Anaemia, unspecified
D64.9 [45600610]
1.1e+00
2.6e+00
—
—
—
1.8e+00
1.0e+00
cases:3.80%
controls:1.32%
cases:6.04%
controls:0.49%
—
—
—
—
—
—
cases:3.02%
controls:0.52%
cases:5.51%
controls:2.03%
17
59
430
4406
27
22
420
4443
—
—
—
13
23
417
4390
19
75
326
3623
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
4.3e-02
7.4e-01
2.1e+00
—
2.0e+00
8.9e-01
6.6e-01
cases:6.04%
controls:5.80%
cases:6.04%
controls:2.98%
cases:3.13%
controls:0.38%
—
—
cases:3.19%
controls:0.43%
cases:7.91%
controls:3.42%
cases:19.42%
controls:11.09%
27
259
420
4206
27
133
420
4332
14
17
433
4448
—
14
19
425
4445
34
151
396
4262
67
410
278
3288
Repeated or continuing anesthesia shots throug a catheter
WX602 [2001310813]
—
—
1.0e+50
1.0e+50
—
3.6e+00
2.8e+00
—
—
—
—
cases:4.47%
controls:0.00%
cases:4.92%
controls:0.00%
—
—
cases:6.51%
controls:0.18%
cases:3.77%
controls:0.24%
—
—
20
0
427
4465
22
0
425
4465
—
28
8
402
4405
13
9
332
3689
Urology
34 [38004474]
5.7e-01
1.4e+00
1.4e+00
—
2.0e+00
1.4e+00
9.5e-01
cases:10.96%
controls:6.49%
cases:10.51%
controls:2.73%
cases:2.01%
controls:0.52%
—
—
cases:2.96%
controls:0.40%
cases:10.23%
controls:2.70%
cases:17.10%
controls:7.41%
49
290
398
4175
47
122
400
4343
9
23
438
4442
—
13
18
426
4446
44
119
386
4294
59
274
286
3424
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
6.4e-01
2.2e+00
1.0e+50
—
—
2.9e+00
1.3e+00
cases:1.57%
controls:0.83%
cases:1.79%
controls:0.20%
cases:1.57%
controls:0.00%
—
—
—
—
cases:2.33%
controls:0.14%
cases:3.77%
controls:1.08%
7
37
440
4428
8
9
439
4456
7
0
440
4465
—
—
10
6
420
4407
13
40
332
3658
Coloscopy
UJF32 [2001305029]
3.7e-01
2.0e+00
3.0e+00
—
—
9.4e-01
1.3e+00
cases:6.04%
controls:4.23%
cases:7.16%
controls:1.01%
cases:2.68%
controls:0.13%
—
—
—
—
cases:3.02%
controls:1.20%
cases:14.20%
controls:4.41%
27
189
420
4276
32
45
415
4420
12
6
435
4459
—
—
13
53
417
4360
49
163
296
3535
Differential panel, method unspecified - Blood
69738-3 [42870588]
2.1e-01
7.1e-01
1.8e+00
—
1.5e+00
1.3e+00
1.1e+00
cases:7.83%
controls:6.43%
cases:8.05%
controls:4.14%
cases:5.15%
controls:0.92%
—
—
cases:3.64%
controls:0.87%
cases:14.65%
controls:4.49%
cases:26.38%
controls:10.87%
35
287
412
4178
36
185
411
4280
23
41
424
4424
—
16
39
423
4425
63
198
367
4215
91
402
254
3296
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
8.0e-01
8.4e-01
3.3e+00
—
—
1.6e+00
1.3e+00
cases:3.80%
controls:1.75%
cases:2.46%
controls:1.08%
cases:5.82%
controls:0.22%
—
—
—
—
cases:4.65%
controls:0.93%
cases:7.83%
controls:2.30%
17
78
430
4387
11
48
436
4417
26
10
421
4455
—
—
20
41
410
4372
27
85
318
3613
Multidisciplinary treatment meeting
WZC20 [2001310890]
—
3.1e+00
1.0e+50
—
1.0e+50
—
3.1e+00
—
—
cases:2.91%
controls:0.13%
cases:2.01%
controls:0.00%
—
—
cases:5.24%
controls:0.00%
—
—
cases:4.06%
controls:0.19%
—
13
6
434
4459
9
0
438
4465
—
23
0
416
4464
—
14
7
331
3691
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
-2.4e-02
7.7e-01
2.2e+00
—
1.8e+00
7.8e-01
6.2e-01
cases:8.50%
controls:8.69%
cases:8.50%
controls:4.12%
cases:4.47%
controls:0.52%
—
—
cases:3.42%
controls:0.58%
cases:9.30%
controls:4.49%
cases:23.77%
controls:14.41%
38
388
409
4077
38
184
409
4281
20
23
427
4442
—
15
26
424
4438
40
198
390
4215
82
533
263
3165
Teaching
WZC30 [2001310891]
4.8e-01
6.7e-01
—
1.0e+50
2.7e+00
2.5e+00
9.5e-01
cases:2.68%
controls:1.68%
cases:1.34%
controls:0.69%
—
—
cases:7.16%
controls:0.00%
cases:2.05%
controls:0.13%
cases:8.14%
controls:0.75%
cases:6.67%
controls:2.68%
12
75
435
4390
6
31
441
4434
—
32
0
415
4465
9
6
430
4458
35
33
395
4380
23
99
322
3599
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
9.8e-02
1.2e+00
2.5e+00
—
—
1.3e+00
1.1e+00
cases:2.91%
controls:2.64%
cases:5.59%
controls:1.70%
cases:3.36%
controls:0.29%
—
—
—
—
cases:6.05%
controls:1.65%
cases:14.49%
controls:5.44%
13
118
434
4347
25
76
422
4389
15
13
432
4452
—
—
26
73
404
4340
50
201
295
3497
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
6.6e-02
7.6e-01
2.1e+00
—
1.9e+00
7.5e-01
6.2e-01
cases:7.38%
controls:6.94%
cases:6.71%
controls:3.27%
cases:3.58%
controls:0.47%
—
—
cases:3.42%
controls:0.52%
cases:8.14%
controls:4.01%
cases:22.32%
controls:13.39%
33
310
414
4155
30
146
417
4319
16
21
431
4444
—
15
23
424
4441
35
177
395
4236
77
495
268
3203
General anesthesia, balanced
WX408 [2001310808]
5.1e-01
1.7e+00
—
—
—
2.8e+00
1.5e+00
cases:6.71%
controls:4.14%
cases:4.25%
controls:0.81%
—
—
—
—
—
—
cases:7.44%
controls:0.50%
cases:7.54%
controls:1.73%
30
185
417
4280
19
36
428
4429
—
—
—
32
22
398
4391
26
64
319
3634
Obstetrics / Gynecology
16 [38004461]
-3.4e-01
9.8e-01
2.7e+00
—
2.3e+00
8.1e-01
3.3e-01
cases:5.37%
controls:7.39%
cases:5.59%
controls:2.17%
cases:4.92%
controls:0.36%
—
—
cases:3.19%
controls:0.31%
cases:4.65%
controls:2.13%
cases:10.43%
controls:7.73%
24
330
423
4135
25
97
422
4368
22
16
425
4449
—
14
14
425
4450
20
94
410
4319
36
286
309
3412
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
2.8e-01
1.2e+00
2.3e+00
—
—
1.4e+00
1.0e+00
cases:3.80%
controls:2.89%
cases:6.26%
controls:1.97%
cases:3.36%
controls:0.34%
—
—
—
—
cases:6.98%
controls:1.88%
cases:14.78%
controls:5.73%
17
129
430
4336
28
88
419
4377
15
15
432
4450
—
—
30
83
400
4330
51
212
294
3486
Monocytes/Leukocytes in Blood
26485-3 [3019069]
9.7e-02
7.3e-01
1.7e+00
—
1.4e+00
1.2e+00
9.2e-01
cases:11.86%
controls:10.88%
cases:12.53%
controls:6.47%
cases:7.16%
controls:1.37%
—
—
cases:5.01%
controls:1.28%
cases:19.30%
controls:6.87%
cases:33.04%
controls:16.47%
53
486
394
3979
56
289
391
4176
32
61
415
4404
—
22
57
417
4407
83
303
347
4110
114
609
231
3089
Internal Medicine
11 [38004456]
3.3e-01
9.3e-01
1.9e+00
—
1.6e+00
8.8e-01
6.8e-01
cases:30.65%
controls:24.05%
cases:20.58%
controls:9.29%
cases:8.95%
controls:1.46%
—
—
cases:5.24%
controls:1.14%
cases:19.07%
controls:8.93%
cases:33.91%
controls:20.66%
137
1074
310
3391
92
415
355
4050
40
65
407
4400
—
23
51
416
4413
82
394
348
4019
117
764
228
2934
Abdominal ultrasound examination
JN3AE [2001305555]
1.8e-01
1.5e+00
—
—
—
2.4e+00
1.9e+00
cases:1.79%
controls:1.50%
cases:2.01%
controls:0.45%
—
—
—
—
—
—
cases:3.72%
controls:0.34%
cases:8.12%
controls:1.24%
8
67
439
4398
9
20
438
4445
—
—
—
16
15
414
4398
28
46
317
3652
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
7.1e-01
1.3e+00
—
—
—
2.6e+00
1.9e+00
cases:3.13%
controls:1.57%
cases:4.25%
controls:1.14%
—
—
—
—
—
—
cases:10.00%
controls:0.79%
cases:16.81%
controls:2.92%
14
70
433
4395
19
51
428
4414
—
—
—
43
35
387
4378
58
108
287
3590
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
2.5e-01
1.2e+00
2.4e+00
—
—
1.3e+00
9.6e-01
cases:3.13%
controls:2.46%
cases:5.37%
controls:1.66%
cases:3.13%
controls:0.29%
—
—
—
—
cases:5.35%
controls:1.52%
cases:11.88%
controls:4.92%
14
110
433
4355
24
74
423
4391
14
13
433
4452
—
—
23
67
407
4346
41
182
304
3516
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
1.2e-01
7.0e-01
1.7e+00
—
1.4e+00
1.2e+00
9.1e-01
cases:12.08%
controls:10.88%
cases:12.30%
controls:6.54%
cases:7.16%
controls:1.37%
—
—
cases:5.01%
controls:1.32%
cases:19.30%
controls:6.91%
cases:32.75%
controls:16.41%
54
486
393
3979
55
292
392
4173
32
61
415
4404
—
22
59
417
4405
83
305
347
4108
113
607
232
3091
Leukocytes [#/volume] in Urine
30405-5 [3018095]
8.4e-02
7.8e-01
2.0e+00
—
1.9e+00
6.4e-01
5.7e-01
cases:8.28%
controls:7.66%
cases:8.05%
controls:3.85%
cases:3.58%
controls:0.52%
—
—
cases:3.64%
controls:0.58%
cases:8.60%
controls:4.71%
cases:23.77%
controls:14.93%
37
342
410
4123
36
172
411
4293
16
23
431
4442
—
16
26
423
4438
37
208
393
4205
82
552
263
3146
Basophils/Leukocytes in Blood
30180-4 [3022096]
1.2e-01
6.8e-01
1.7e+00
—
1.4e+00
1.2e+00
8.8e-01
cases:12.08%
controls:10.84%
cases:12.08%
controls:6.49%
cases:7.16%
controls:1.37%
—
—
cases:5.01%
controls:1.32%
cases:19.30%
controls:6.93%
cases:32.46%
controls:16.60%
54
484
393
3981
54
290
393
4175
32
61
415
4404
—
22
59
417
4405
83
306
347
4107
112
614
233
3084
Eosinophils [#/volume] in Blood
26449-9 [3013115]
1.5e-01
6.7e-01
1.7e+00
—
1.4e+00
1.1e+00
8.0e-01
cases:14.09%
controls:12.34%
cases:13.65%
controls:7.46%
cases:8.05%
controls:1.52%
—
—
cases:5.69%
controls:1.43%
cases:20.93%
controls:8.00%
cases:35.36%
controls:19.66%
63
551
384
3914
61
333
386
4132
36
68
411
4397
—
25
64
414
4400
90
353
340
4060
122
727
223
2971
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
7.6e-02
7.1e-01
1.7e+00
—
1.3e+00
1.0e+00
8.7e-01
cases:11.86%
controls:11.09%
cases:12.53%
controls:6.56%
cases:6.71%
controls:1.25%
—
—
cases:4.78%
controls:1.30%
cases:17.67%
controls:7.09%
cases:32.75%
controls:16.93%
53
495
394
3970
56
293
391
4172
30
56
417
4409
—
21
58
418
4406
76
313
354
4100
113
626
232
3072
Monocytes [#/volume] in Blood
26484-6 [3001604]
1.5e-01
6.9e-01
1.7e+00
—
1.3e+00
1.1e+00
8.3e-01
cases:13.20%
controls:11.56%
cases:13.20%
controls:7.10%
cases:8.05%
controls:1.50%
—
—
cases:5.24%
controls:1.43%
cases:19.77%
controls:7.64%
cases:34.78%
controls:18.93%
59
516
388
3949
59
317
388
4148
36
67
411
4398
—
23
64
416
4400
85
337
345
4076
120
700
225
2998
Basophils [#/volume] in Blood
26444-0 [3006315]
1.5e-01
6.8e-01
1.7e+00
—
1.3e+00
1.1e+00
8.2e-01
cases:13.20%
controls:11.58%
cases:13.20%
controls:7.14%
cases:8.05%
controls:1.50%
—
—
cases:5.24%
controls:1.46%
cases:19.77%
controls:7.73%
cases:34.78%
controls:18.98%
59
517
388
3948
59
319
388
4146
36
67
411
4398
—
23
65
416
4399
85
341
345
4072
120
702
225
2996
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
-2.4e-02
6.2e-01
—
—
2.9e+00
1.6e+00
1.2e+00
cases:4.03%
controls:4.12%
cases:3.13%
controls:1.70%
—
—
—
—
cases:3.42%
controls:0.20%
cases:9.53%
controls:2.06%
cases:20.00%
controls:7.25%
18
184
429
4281
14
76
433
4389
—
—
15
9
424
4455
41
91
389
4322
69
268
276
3430
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
9.6e-02
7.0e-01
1.7e+00
—
1.3e+00
1.1e+00
8.6e-01
cases:12.30%
controls:11.31%
cases:12.75%
controls:6.74%
cases:6.94%
controls:1.37%
—
—
cases:4.56%
controls:1.32%
cases:18.37%
controls:7.27%
cases:33.04%
controls:17.33%
55
505
392
3960
57
301
390
4164
31
61
416
4404
—
20
59
419
4405
79
321
351
4092
114
641
231
3057
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
1.0e-01
6.0e-01
1.7e+00
—
1.3e+00
1.0e+00
7.9e-01
cases:13.42%
controls:12.25%
cases:12.98%
controls:7.55%
cases:8.05%
controls:1.50%
—
—
cases:5.24%
controls:1.50%
cases:19.77%
controls:8.04%
cases:35.07%
controls:19.63%
60
547
387
3918
58
337
389
4128
36
67
411
4398
—
23
67
416
4397
85
355
345
4058
121
726
224
2972
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
—
—
—
—
—
2.9e+00
2.5e+00
—
—
—
—
—
—
—
—
—
—
cases:2.79%
controls:0.16%
cases:2.61%
controls:0.22%
—
—
—
—
—
12
7
418
4406
9
8
336
3690
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1.0e-01
5.5e-01
2.0e+00
—
1.6e+00
7.8e-01
4.3e-01
cases:44.07%
controls:41.52%
cases:45.86%
controls:32.92%
cases:30.65%
controls:5.60%
—
—
cases:22.32%
controls:5.33%
cases:54.65%
controls:35.67%
cases:74.78%
controls:65.77%
197
1854
250
2611
205
1470
242
2995
137
250
310
4215
—
98
238
341
4226
235
1574
195
2839
258
2432
87
1266
Melaena
K92.1 [45533624]
7.6e-01
3.5e+00
1.0e+50
—
1.0e+50
—
1.7e+00
cases:1.57%
controls:0.74%
cases:5.82%
controls:0.18%
cases:4.70%
controls:0.00%
—
—
cases:2.51%
controls:0.00%
—
—
cases:2.90%
controls:0.57%
7
33
440
4432
26
8
421
4457
21
0
426
4465
—
11
0
428
4464
—
10
21
335
3677
12 lead EKG panel
34534-8 [3044889]
1.6e-01
5.9e-01
2.6e+00
—
1.5e+00
5.0e-01
2.3e-01
cases:26.40%
controls:23.40%
cases:21.92%
controls:13.46%
cases:19.69%
controls:1.75%
—
—
cases:6.38%
controls:1.55%
cases:21.16%
controls:13.98%
cases:39.71%
controls:34.32%
118
1045
329
3420
98
601
349
3864
88
78
359
4387
—
28
69
411
4395
91
617
339
3796
137
1269
208
2429
Emergency Medicine
93 [38004510]
-1.4e-01
5.5e-01
2.4e+00
1.0e+50
1.3e+00
4.9e-01
4.5e-01
cases:14.99%
controls:16.86%
cases:14.99%
controls:9.20%
cases:11.41%
controls:1.19%
cases:1.34%
controls:0.00%
cases:4.33%
controls:1.25%
cases:15.81%
controls:10.33%
cases:39.13%
controls:29.07%
67
753
380
3712
67
411
380
4054
51
53
396
4412
6
0
441
4465
19
56
420
4408
68
456
362
3957
135
1075
210
2623
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
1.5e-01
4.3e-01
2.4e+00
—
2.7e+00
4.8e-01
5.0e-01
cases:4.92%
controls:4.28%
cases:2.68%
controls:1.77%
cases:2.68%
controls:0.25%
—
—
cases:2.51%
controls:0.18%
cases:3.26%
controls:2.04%
cases:10.14%
controls:6.41%
22
191
425
4274
12
79
435
4386
12
11
435
4454
—
11
8
428
4456
14
90
416
4323
35
237
310
3461
Removal of sutures
SPAT1153 [2001700254]
1.9e-01
8.1e-02
—
—
3.6e+00
1.4e+00
4.9e-01
cases:8.28%
controls:6.97%
cases:2.01%
controls:1.86%
—
—
—
—
cases:5.69%
controls:0.16%
cases:5.12%
controls:1.34%
cases:8.12%
controls:5.14%
37
311
410
4154
9
83
438
4382
—
—
25
7
414
4457
22
59
408
4354
28
190
317
3508
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M
77147-7 [46236952]
—
1.0e+00
2.2e+00
—
—
1.6e+00
1.2e+00
—
—
cases:2.46%
controls:0.90%
cases:1.57%
controls:0.18%
—
—
—
—
cases:4.19%
controls:0.84%
cases:7.83%
controls:2.51%
—
11
40
436
4425
7
8
440
4457
—
—
18
37
412
4376
27
93
318
3605
Case Management Agency
251B00000X [38004193]
9.5e-02
2.9e-01
9.6e-01
2.1e+00
1.2e+00
7.6e-01
3.9e-01
cases:78.52%
controls:76.89%
cases:74.72%
controls:68.87%
cases:48.99%
controls:26.81%
cases:12.08%
controls:1.72%
cases:56.26%
controls:27.37%
cases:84.88%
controls:72.42%
cases:91.01%
controls:87.32%
351
3433
96
1032
334
3075
113
1390
219
1197
228
3268
54
77
393
4388
247
1222
192
3242
365
3196
65
1217
314
3229
31
469
Gastroscopy
UJD02 [2001304787]
—
2.5e+00
1.0e+50
1.0e+50
—
—
2.5e+00
—
—
cases:1.34%
controls:0.11%
cases:1.79%
controls:0.00%
cases:1.12%
controls:0.00%
—
—
—
—
cases:2.61%
controls:0.22%
—
6
5
441
4460
8
0
439
4465
5
0
442
4465
—
—
9
8
336
3690
Thoracic and Cardiac Surgery
OMOP4822009 [45756830]
2.8e-02
1.4e+00
—
—
—
2.2e+00
1.4e+00
cases:1.57%
controls:1.52%
cases:2.68%
controls:0.67%
—
—
—
—
—
—
cases:3.26%
controls:0.36%
cases:4.93%
controls:1.33%
7
68
440
4397
12
30
435
4435
—
—
—
14
16
416
4397
17
49
328
3649
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
1.8e-01
2.6e-01
1.8e+00
—
2.2e+00
7.8e-01
3.3e-01
cases:6.71%
controls:5.69%
cases:4.25%
controls:3.31%
cases:3.80%
controls:0.63%
—
—
cases:3.64%
controls:0.43%
cases:5.58%
controls:2.63%
cases:6.96%
controls:5.08%
30
254
417
4211
19
148
428
4317
17
28
430
4437
—
16
19
423
4445
24
116
406
4297
24
188
321
3510
oxycodone and naloxone; oral
N02AA55 [21604265]
-5.3e-01
5.4e-01
—
—
3.0e+00
1.7e+00
4.8e-01
cases:1.57%
controls:2.62%
cases:1.57%
controls:0.92%
—
—
—
—
cases:3.64%
controls:0.18%
cases:5.35%
controls:1.02%
cases:6.09%
controls:3.84%
7
117
440
4348
7
41
440
4424
—
—
16
8
423
4456
23
45
407
4368
21
142
324
3556
oxycodone; oral, parenteral
N02AA05 [21604260]
2.5e-02
3.6e-01
—
—
2.4e+00
1.4e+00
9.3e-01
cases:1.79%
controls:1.75%
cases:1.34%
controls:0.94%
—
—
—
—
cases:3.64%
controls:0.36%
cases:4.88%
controls:1.22%
cases:7.54%
controls:3.11%
8
78
439
4387
6
42
441
4423
—
—
16
16
423
4448
21
54
409
4359
26
115
319
3583
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
1.0e-01
8.2e-01
2.1e+00
—
1.7e+00
6.7e-01
7.5e-01
cases:5.15%
controls:4.68%
cases:4.25%
controls:1.93%
cases:2.24%
controls:0.27%
—
—
cases:1.82%
controls:0.34%
cases:3.49%
controls:1.81%
cases:13.91%
controls:7.11%
23
209
424
4256
19
86
428
4379
10
12
437
4453
—
8
15
431
4449
15
80
415
4333
48
263
297
3435
X-ray mammography
HA1AA [2001303884]
2.3e+00
—
—
—
—
—
2.2e+00
cases:1.34%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:3.19%
controls:0.35%
6
6
441
4459
—
—
—
—
—
11
13
334
3685
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
7.4e-02
6.8e-01
1.4e+00
—
1.5e+00
4.8e-01
4.4e-01
cases:20.13%
controls:18.97%
cases:18.34%
controls:10.26%
cases:6.26%
controls:1.59%
—
—
cases:5.92%
controls:1.39%
cases:16.51%
controls:10.88%
cases:36.81%
controls:27.29%
90
847
357
3618
82
458
365
4007
28
71
419
4394
—
26
62
413
4402
71
480
359
3933
127
1009
218
2689
Gas panel - Venous blood
24339-4 [3000991]
4.8e-01
8.5e-01
—
1.0e+50
2.7e+00
1.7e+00
7.0e-01
cases:2.01%
controls:1.25%
cases:1.57%
controls:0.67%
—
—
cases:4.92%
controls:0.00%
cases:2.05%
controls:0.13%
cases:4.42%
controls:0.86%
cases:6.96%
controls:3.57%
9
56
438
4409
7
30
440
4435
—
22
0
425
4465
9
6
430
4458
19
38
411
4375
24
132
321
3566
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
3.4e-01
9.3e-01
2.4e+00
—
—
1.1e+00
8.5e-01
cases:3.13%
controls:2.24%
cases:3.13%
controls:1.25%
cases:2.24%
controls:0.20%
—
—
—
—
cases:3.72%
controls:1.25%
cases:7.54%
controls:3.38%
14
100
433
4365
14
56
433
4409
10
9
437
4456
—
—
16
55
414
4358
26
125
319
3573
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
-3.5e-01
3.1e-01
3.2e+00
—
—
1.2e+00
5.9e-01
cases:2.24%
controls:3.14%
cases:1.79%
controls:1.32%
cases:3.58%
controls:0.16%
—
—
—
—
cases:4.19%
controls:1.27%
cases:8.70%
controls:5.03%
10
140
437
4325
8
59
439
4406
16
7
431
4458
—
—
18
56
412
4357
30
186
315
3512
More than one and less than three hours
ZXE10 [2001311401]
4.1e-01
1.1e+00
—
1.0e+50
—
2.0e+00
1.3e+00
cases:8.95%
controls:6.14%
cases:4.47%
controls:1.57%
—
—
cases:6.04%
controls:0.00%
—
—
cases:5.81%
controls:0.84%
cases:10.14%
controls:2.95%
40
274
407
4191
20
70
427
4395
—
27
0
420
4465
—
25
37
405
4376
35
109
310
3589
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
1.2e-01
8.7e-01
2.2e+00
—
2.2e+00
7.6e-01
5.0e-01
cases:3.13%
controls:2.78%
cases:3.36%
controls:1.43%
cases:1.34%
controls:0.16%
—
—
cases:1.82%
controls:0.20%
cases:4.42%
controls:2.11%
cases:10.72%
controls:6.76%
14
124
433
4341
15
64
432
4401
6
7
441
4458
—
8
9
431
4455
19
93
411
4320
37
250
308
3448
Pharmacy visit
OMOP4822462 [581458]
-2.9e-02
7.3e-01
7.3e-01
4.1e-01
1.4e+00
1.5e+00
1.3e+00
cases:95.30%
controls:95.43%
cases:94.63%
controls:89.45%
cases:71.81%
controls:55.14%
cases:4.47%
controls:3.00%
cases:82.69%
controls:54.50%
cases:97.67%
controls:90.39%
cases:99.13%
controls:96.73%
426
4261
21
204
423
3994
24
471
321
2462
126
2003
20
134
427
4331
363
2433
76
2031
420
3989
10
424
342
3577
3
121
Hypothyroidism, unspecified
E03.9 [45537945]
4.3e-02
4.2e-01
1.9e+00
1.0e+50
2.5e+00
8.4e-01
2.4e-01
cases:2.68%
controls:2.58%
cases:1.57%
controls:1.03%
cases:1.57%
controls:0.25%
cases:1.79%
controls:0.00%
cases:1.82%
controls:0.16%
cases:2.79%
controls:1.22%
cases:4.35%
controls:3.46%
12
115
435
4350
7
46
440
4419
7
11
440
4454
8
0
439
4465
8
7
431
4457
12
54
418
4359
15
128
330
3570
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
—
—
—
1.0e+50
2.7e+00
1.6e+00
8.4e-01
—
—
—
—
—
—
cases:4.47%
controls:0.00%
cases:1.59%
controls:0.11%
cases:2.79%
controls:0.57%
cases:4.06%
controls:1.78%
—
—
—
20
0
427
4465
7
5
432
4459
12
25
418
4388
14
66
331
3632
Endocrinology
46 [38004485]
5.1e-01
1.5e+00
1.4e+00
—
1.2e+00
1.8e+00
1.0e+00
cases:4.25%
controls:2.60%
cases:5.59%
controls:1.37%
cases:1.12%
controls:0.27%
—
—
cases:1.14%
controls:0.36%
cases:9.07%
controls:1.61%
cases:9.28%
controls:3.57%
19
116
428
4349
25
61
422
4404
5
12
442
4453
—
5
16
434
4448
39
71
391
4342
32
132
313
3566
More than three and less than five hours
ZXE20 [2001311408]
5.2e-01
1.8e+00
1.0e+50
1.0e+50
—
2.4e+00
1.1e+00
cases:3.13%
controls:1.88%
cases:2.46%
controls:0.40%
cases:3.58%
controls:0.00%
cases:2.46%
controls:0.00%
—
—
cases:3.02%
controls:0.27%
cases:2.32%
controls:0.78%
14
84
433
4381
11
18
436
4447
16
0
431
4465
11
0
436
4465
—
13
12
417
4401
8
29
337
3669
Oxygen saturation in Arterial blood
2708-6 [3016502]
1.8e-01
6.6e-01
—
1.0e+50
2.7e+00
1.5e+00
6.2e-01
cases:1.79%
controls:1.50%
cases:1.12%
controls:0.58%
—
—
cases:5.15%
controls:0.00%
cases:2.05%
controls:0.13%
cases:4.65%
controls:1.07%
cases:6.96%
controls:3.87%
8
67
439
4398
5
26
442
4439
—
23
0
424
4465
9
6
430
4458
20
47
410
4366
24
143
321
3555
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
-6.0e-02
7.7e-01
—
1.0e+50
2.5e+00
1.8e+00
5.4e-01
cases:1.12%
controls:1.19%
cases:1.34%
controls:0.63%
—
—
cases:4.92%
controls:0.00%
cases:2.05%
controls:0.18%
cases:4.19%
controls:0.73%
cases:5.51%
controls:3.27%
5
53
442
4412
6
28
441
4437
—
22
0
425
4465
9
8
430
4456
18
32
412
4381
19
121
326
3577
Iron deficiency anaemia, unspecified
D50.9 [45605373]
6.8e-01
2.7e+00
—
—
—
1.6e+00
7.4e-01
cases:2.24%
controls:1.14%
cases:4.03%
controls:0.29%
—
—
—
—
—
—
cases:2.56%
controls:0.54%
cases:3.19%
controls:1.54%
10
51
437
4414
18
13
429
4452
—
—
—
11
24
419
4389
11
57
334
3641
dexamethasone; oral, parenteral
H02AB02 [21602730]
5.6e-01
2.1e+00
—
—
—
1.3e+00
8.9e-01
cases:2.91%
controls:1.68%
cases:3.80%
controls:0.49%
—
—
—
—
—
—
cases:3.02%
controls:0.88%
cases:6.67%
controls:2.84%
13
75
434
4390
17
22
430
4443
—
—
—
13
39
417
4374
23
105
322
3593
Other obesity
E66.8 [45533036]
7.8e-01
2.2e+00
1.0e+50
1.0e+50
1.0e+50
2.0e+00
9.2e-01
cases:1.79%
controls:0.83%
cases:2.24%
controls:0.25%
cases:2.01%
controls:0.00%
cases:1.79%
controls:0.00%
cases:1.82%
controls:0.00%
cases:2.09%
controls:0.29%
cases:1.74%
controls:0.70%
8
37
439
4428
10
11
437
4454
9
0
438
4465
8
0
439
4465
8
0
431
4464
9
13
421
4400
6
26
339
3672
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
7.4e-02
7.4e-01
—
1.0e+50
2.7e+00
1.5e+00
7.5e-01
cases:1.57%
controls:1.46%
cases:1.12%
controls:0.54%
—
—
cases:5.59%
controls:0.00%
cases:2.28%
controls:0.16%
cases:4.42%
controls:1.02%
cases:6.96%
controls:3.41%
7
65
440
4400
5
24
442
4441
—
25
0
422
4465
10
7
429
4457
19
45
411
4368
24
126
321
3572
pH of Specimen
17433-4 [3019225]
-1.4e-01
2.7e-01
2.1e+00
—
2.2e+00
1.1e+00
8.6e-01
cases:2.24%
controls:2.55%
cases:2.01%
controls:1.55%
cases:1.12%
controls:0.13%
—
—
cases:1.82%
controls:0.20%
cases:4.19%
controls:1.45%
cases:6.67%
controls:2.92%
10
114
437
4351
9
69
438
4396
5
6
442
4459
—
8
9
431
4455
18
64
412
4349
23
108
322
3590
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
3.9e-01
4.9e-01
—
—
2.1e+00
1.0e+00
1.0e+00
cases:9.40%
controls:6.56%
cases:5.82%
controls:3.63%
—
—
—
—
cases:2.73%
controls:0.34%
cases:9.07%
controls:3.51%
cases:22.61%
controls:9.55%
42
293
405
4172
26
162
421
4303
—
—
12
15
427
4449
39
155
391
4258
78
353
267
3345
Pathology report gross observation
24419-4 [3002256]
1.6e-02
6.6e-01
—
1.0e+50
—
2.7e+00
1.4e+00
cases:1.34%
controls:1.32%
cases:1.12%
controls:0.58%
—
—
cases:9.62%
controls:0.00%
—
—
cases:5.35%
controls:0.36%
cases:6.38%
controls:1.73%
6
59
441
4406
5
26
442
4439
—
43
0
404
4465
—
23
16
407
4397
22
64
323
3634
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
2.4e-01
3.6e-01
9.7e-01
1.8e+00
2.1e+00
6.2e-01
1.7e-01
cases:47.43%
controls:41.59%
cases:30.87%
controls:23.72%
cases:11.86%
controls:4.84%
cases:1.34%
controls:0.22%
cases:29.84%
controls:4.82%
cases:37.44%
controls:24.27%
cases:51.59%
controls:47.30%
212
1857
235
2608
138
1059
309
3406
53
216
394
4249
6
10
441
4455
131
215
308
4249
161
1071
269
3342
178
1749
167
1949
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
5.2e-01
1.0e+00
2.9e+00
—
—
1.2e+00
7.0e-01
cases:2.24%
controls:1.34%
cases:2.46%
controls:0.90%
cases:2.46%
controls:0.13%
—
—
—
—
cases:3.02%
controls:0.97%
cases:4.93%
controls:2.51%
10
60
437
4405
11
40
436
4425
11
6
436
4459
—
—
13
43
417
4370
17
93
328
3605
Osmolality of Urine
2695-5 [3026782]
1.1e-01
7.6e-01
2.1e+00
—
1.9e+00
7.4e-01
5.9e-01
cases:6.04%
controls:5.42%
cases:4.47%
controls:2.15%
cases:2.24%
controls:0.27%
—
—
cases:1.82%
controls:0.27%
cases:3.72%
controls:1.81%
cases:11.01%
controls:6.44%
27
242
420
4223
20
96
427
4369
10
12
437
4453
—
8
12
431
4452
16
80
414
4333
38
238
307
3460
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
1.6e-01
6.2e-01
—
1.0e+50
2.5e+00
1.5e+00
5.0e-01
cases:2.24%
controls:1.90%
cases:1.57%
controls:0.85%
—
—
cases:6.26%
controls:0.00%
cases:2.51%
controls:0.20%
cases:4.88%
controls:1.13%
cases:6.38%
controls:3.98%
10
85
437
4380
7
38
440
4427
—
28
0
419
4465
11
9
428
4455
21
50
409
4363
22
147
323
3551
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
1.6e-01
6.2e-01
—
1.0e+50
2.5e+00
1.5e+00
4.9e-01
cases:2.24%
controls:1.90%
cases:1.57%
controls:0.85%
—
—
cases:6.26%
controls:0.00%
cases:2.51%
controls:0.20%
cases:4.88%
controls:1.13%
cases:6.38%
controls:4.00%
10
85
437
4380
7
38
440
4427
—
28
0
419
4465
11
9
428
4455
21
50
409
4363
22
148
323
3550
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
-7.0e-02
7.4e-01
2.0e+00
—
2.0e+00
7.1e-01
4.6e-01
cases:2.24%
controls:2.40%
cases:3.13%
controls:1.52%
cases:1.34%
controls:0.18%
—
—
cases:1.82%
controls:0.25%
cases:4.65%
controls:2.33%
cases:11.59%
controls:7.68%
10
107
437
4358
14
68
433
4397
6
8
441
4457
—
8
11
431
4453
20
103
410
4310
40
284
305
3414
Excision of other lesion extending through all layers of skin in head or neck
QAE10 [2001309784]
1.9e+00
—
—
—
—
—
2.1e+00
cases:1.79%
controls:0.27%
—
—
—
—
—
—
—
—
—
—
cases:1.74%
controls:0.22%
8
12
439
4453
—
—
—
—
—
6
8
339
3690
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
6.7e-02
5.8e-01
2.0e+00
—
1.4e+00
4.4e-01
3.8e-01
cases:17.00%
controls:16.08%
cases:13.65%
controls:8.11%
cases:7.16%
controls:1.01%
—
—
cases:4.56%
controls:1.16%
cases:12.33%
controls:8.27%
cases:31.01%
controls:23.58%
76
718
371
3747
61
362
386
4103
32
45
415
4420
—
20
52
419
4412
53
365
377
4048
107
872
238
2826
Pain localized to upper abdomen
R10.1 [45568111]
-2.4e-01
1.3e+00
—
—
—
1.7e+00
9.9e-01
cases:2.01%
controls:2.55%
cases:2.68%
controls:0.72%
—
—
—
—
—
—
cases:3.26%
controls:0.63%
cases:6.96%
controls:2.70%
9
114
438
4351
12
32
435
4433
—
—
—
14
28
416
4385
24
100
321
3598
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
-2.8e-01
5.9e-01
—
—
—
2.3e+00
1.7e+00
cases:1.12%
controls:1.48%
cases:1.57%
controls:0.87%
—
—
—
—
—
—
cases:6.74%
controls:0.73%
cases:12.75%
controls:2.65%
5
66
442
4399
7
39
440
4426
—
—
—
29
32
401
4381
44
98
301
3600
EKG study
11524-6 [3013512]
3.1e-02
1.7e-01
2.2e+00
—
1.7e+00
5.4e-01
3.1e-01
cases:10.07%
controls:9.79%
cases:6.49%
controls:5.53%
cases:6.71%
controls:0.76%
—
—
cases:2.96%
controls:0.54%
cases:9.30%
controls:5.64%
cases:19.71%
controls:15.20%
45
437
402
4028
29
247
418
4218
30
34
417
4431
—
13
24
426
4440
40
249
390
4164
68
562
277
3136
pH of Arterial blood
2744-1 [3019977]
1.6e-01
6.2e-01
—
1.0e+50
2.4e+00
1.5e+00
6.9e-01
cases:2.24%
controls:1.90%
cases:1.57%
controls:0.85%
—
—
cases:6.26%
controls:0.00%
cases:2.51%
controls:0.22%
cases:4.88%
controls:1.11%
cases:7.54%
controls:3.92%
10
85
437
4380
7
38
440
4427
—
28
0
419
4465
11
10
428
4454
21
49
409
4364
26
145
319
3553
ferrous glycine sulfate; oral
B03AA01 [21601080]
9.1e-01
1.6e+00
—
—
2.3e+00
1.4e+00
6.6e-01
cases:2.46%
controls:1.01%
cases:2.01%
controls:0.40%
—
—
—
—
cases:1.14%
controls:0.11%
cases:1.86%
controls:0.48%
cases:3.19%
controls:1.68%
11
45
436
4420
9
18
438
4447
—
—
5
5
434
4459
8
21
422
4392
11
62
334
3636
Emergency Room and Inpatient Visit
ERIP [262]
8.5e-02
1.1e+00
2.3e+00
1.0e+50
1.3e+00
3.8e-01
5.3e-01
cases:5.15%
controls:4.75%
cases:8.28%
controls:2.89%
cases:5.59%
controls:0.58%
cases:1.34%
controls:0.00%
cases:2.28%
controls:0.65%
cases:6.28%
controls:4.37%
cases:21.74%
controls:14.09%
23
212
424
4253
37
129
410
4336
25
26
422
4439
6
0
441
4465
10
29
429
4435
27
193
403
4220
75
521
270
3177
Base excess in Arterial blood by calculation
1925-7 [3003396]
1.5e-01
6.2e-01
—
1.0e+50
2.3e+00
1.5e+00
6.8e-01
cases:2.24%
controls:1.93%
cases:1.57%
controls:0.85%
—
—
cases:6.04%
controls:0.00%
cases:2.28%
controls:0.22%
cases:4.88%
controls:1.11%
cases:7.54%
controls:3.98%
10
86
437
4379
7
38
440
4427
—
27
0
420
4465
10
10
429
4454
21
49
409
4364
26
147
319
3551
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
5.6e-01
1.6e+00
—
—
—
1.3e+00
8.4e-01
cases:3.80%
controls:2.22%
cases:2.46%
controls:0.52%
—
—
—
—
—
—
cases:3.49%
controls:0.95%
cases:6.09%
controls:2.73%
17
99
430
4366
11
23
436
4442
—
—
—
15
42
415
4371
21
101
324
3597
General anaesthesia
WX402 [2001310806]
2.8e-01
1.2e+00
—
1.0e+50
—
2.5e+00
6.2e-01
cases:2.01%
controls:1.52%
cases:2.68%
controls:0.78%
—
—
cases:11.19%
controls:0.00%
—
—
cases:8.14%
controls:0.75%
cases:6.38%
controls:3.54%
9
68
438
4397
12
35
435
4430
—
50
0
397
4465
—
35
33
395
4380
22
131
323
3567
Laceration/cut
S18 [2002000983]
2.3e-01
3.1e-01
—
—
2.9e+00
8.1e-01
3.4e-01
cases:11.86%
controls:9.65%
cases:4.47%
controls:3.31%
—
—
—
—
cases:8.43%
controls:0.52%
cases:8.14%
controls:3.78%
cases:16.23%
controls:12.11%
53
431
394
4034
20
148
427
4317
—
—
37
23
402
4441
35
167
395
4246
56
448
289
3250
Ultrasound measurement of residual urine
KC1EE [2001305918]
2.0e-01
1.3e+00
—
—
2.3e+00
2.8e-01
6.1e-01
cases:2.91%
controls:2.40%
cases:2.91%
controls:0.83%
—
—
—
—
cases:1.14%
controls:0.11%
cases:1.16%
controls:0.88%
cases:4.93%
controls:2.73%
13
107
434
4358
13
37
434
4428
—
—
5
5
434
4459
5
39
425
4374
17
101
328
3597
General Practice
1 [38004446]
4.1e-02
4.3e-01
1.7e+00
—
1.9e+00
2.0e-01
3.5e-01
cases:16.11%
controls:15.57%
cases:9.17%
controls:6.14%
cases:4.25%
controls:0.78%
—
—
cases:4.56%
controls:0.74%
cases:8.37%
controls:6.93%
cases:24.35%
controls:18.42%
72
695
375
3770
41
274
406
4191
19
35
428
4430
—
20
33
419
4431
36
306
394
4107
84
681
261
3017
Cathetrisation of vein
TPH04 [2001309597]
-2.8e-01
1.6e+00
—
1.0e+50
—
1.8e+00
7.3e-01
cases:2.46%
controls:3.23%
cases:4.92%
controls:0.99%
—
—
cases:4.25%
controls:0.00%
—
—
cases:5.35%
controls:0.88%
cases:7.25%
controls:3.62%
11
144
436
4321
22
44
425
4421
—
19
0
428
4465
—
23
39
407
4374
25
134
320
3564
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
-3.1e-02
5.6e-01
1.9e+00
—
1.5e+00
5.3e-01
3.0e-01
cases:10.07%
controls:10.35%
cases:9.84%
controls:5.87%
cases:4.70%
controls:0.72%
—
—
cases:2.96%
controls:0.67%
cases:9.07%
controls:5.55%
cases:21.45%
controls:16.79%
45
462
402
4003
44
262
403
4203
21
32
426
4433
—
13
30
426
4434
39
245
391
4168
74
621
271
3077
Intravenous general anesthesia
WX404 [2001310807]
6.5e-01
1.1e+00
—
1.0e+50
—
1.9e+00
1.5e+00
cases:4.92%
controls:2.64%
cases:2.68%
controls:0.94%
—
—
cases:1.79%
controls:0.00%
—
—
cases:2.56%
controls:0.39%
cases:4.93%
controls:1.16%
22
118
425
4347
12
42
435
4423
—
8
0
439
4465
—
11
17
419
4396
17
43
328
3655
Neoplasm of uncertain or unknown behaviour: Other digestive organs
D37.7 [45552349]
2.1e+00
—
1.0e+50
1.0e+50
—
—
3.3e+00
cases:1.12%
controls:0.13%
—
—
cases:4.92%
controls:0.00%
cases:2.46%
controls:0.00%
—
—
—
—
cases:4.35%
controls:0.16%
5
6
442
4459
—
22
0
425
4465
11
0
436
4465
—
—
15
6
330
3692
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
—
—
1.0e+50
1.0e+50
—
3.3e+00
1.5e+00
—
—
—
—
cases:1.79%
controls:0.00%
cases:1.57%
controls:0.00%
—
—
cases:3.02%
controls:0.11%
cases:2.61%
controls:0.62%
—
—
8
0
439
4465
7
0
440
4465
—
13
5
417
4408
9
23
336
3675
Thoracal epidural anesthesia
WX302 [2001310795]
—
—
1.0e+50
1.0e+50
—
1.0e+50
3.3e+00
—
—
—
—
cases:4.25%
controls:0.00%
cases:5.59%
controls:0.00%
—
—
cases:5.58%
controls:0.00%
cases:4.06%
controls:0.16%
—
—
19
0
428
4465
25
0
422
4465
—
24
0
406
4413
14
6
331
3692
oxazepam; oral
N05BA04 [21604569]
5.6e-01
8.1e-01
1.4e+00
—
1.2e+00
9.5e-01
6.5e-01
cases:8.50%
controls:5.02%
cases:5.82%
controls:2.67%
cases:2.68%
controls:0.67%
—
—
cases:2.51%
controls:0.78%
cases:6.74%
controls:2.72%
cases:9.86%
controls:5.38%
38
224
409
4241
26
119
421
4346
12
30
435
4435
—
11
35
428
4429
29
120
401
4293
34
199
311
3499
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
3.9e-01
8.4e-01
1.5e+00
—
—
7.7e-01
5.4e-01
cases:5.59%
controls:3.87%
cases:4.92%
controls:2.19%
cases:2.68%
controls:0.58%
—
—
—
—
cases:6.05%
controls:2.90%
cases:12.17%
controls:7.49%
25
173
422
4292
22
98
425
4367
12
26
435
4439
—
—
26
128
404
4285
42
277
303
3421
Pain localized to other parts of lower abdomen
R10.3 [45534426]
-1.0e-02
1.1e+00
2.0e+00
—
—
—
3.7e-01
cases:2.46%
controls:2.49%
cases:2.91%
controls:0.96%
cases:1.34%
controls:0.18%
—
—
—
—
—
—
cases:4.93%
controls:3.46%
11
111
436
4354
13
43
434
4422
6
8
441
4457
—
—
—
17
128
328
3570
Telehealth
OMOP5556618 [722455]
2.0e-01
4.3e-01
1.1e+00
—
1.2e+00
4.8e-01
1.9e-01
cases:38.03%
controls:33.37%
cases:19.69%
controls:13.73%
cases:5.37%
controls:1.93%
—
—
cases:7.06%
controls:2.33%
cases:18.60%
controls:12.42%
cases:27.25%
controls:23.72%
170
1490
277
2975
88
613
359
3852
24
86
423
4379
—
31
104
408
4360
80
548
350
3865
94
877
251
2821
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
1.0e-01
5.3e-01
—
—
2.1e+00
9.7e-01
3.3e-01
cases:7.61%
controls:6.92%
cases:2.91%
controls:1.72%
—
—
—
—
cases:1.59%
controls:0.20%
cases:3.72%
controls:1.45%
cases:7.83%
controls:5.73%
34
309
413
4156
13
77
434
4388
—
—
7
9
432
4455
16
64
414
4349
27
212
318
3486
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
4.0e-02
—
—
1.0e+50
—
2.1e+00
9.4e-01
cases:1.12%
controls:1.08%
—
—
—
—
cases:4.92%
controls:0.00%
—
—
cases:4.42%
controls:0.59%
cases:6.38%
controls:2.60%
5
48
442
4417
—
—
22
0
425
4465
—
19
26
411
4387
22
96
323
3602
Treatment-related counselling outside office
SPAT1249 [2001700350]
1.4e-01
4.4e-01
1.6e+00
—
1.4e+00
2.6e-01
1.8e-01
cases:13.42%
controls:11.85%
cases:7.61%
controls:5.04%
cases:2.01%
controls:0.43%
—
—
cases:2.28%
controls:0.56%
cases:5.81%
controls:4.55%
cases:13.62%
controls:11.63%
60
529
387
3936
34
225
413
4240
9
19
438
4446
—
10
25
429
4439
25
201
405
4212
47
430
298
3268
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
14928-6 [3026989]
—
—
—
—
—
1.7e+00
1.3e+00
—
—
—
—
—
—
—
—
—
—
cases:2.09%
controls:0.41%
cases:4.93%
controls:1.43%
—
—
—
—
—
9
18
421
4395
17
53
328
3645
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
-2.5e-02
5.7e-01
1.2e+00
—
1.2e+00
2.4e-01
2.2e-01
cases:19.46%
controls:19.87%
cases:17.45%
controls:10.66%
cases:5.37%
controls:1.72%
—
—
cases:4.56%
controls:1.46%
cases:14.19%
controls:11.51%
cases:33.04%
controls:28.31%
87
887
360
3578
78
476
369
3989
24
77
423
4388
—
20
65
419
4399
61
508
369
3905
114
1047
231
2651
Ultrasound examination of mammary glands
HA1AE [2001303886]
2.3e+00
—
—
—
—
1.0e+50
2.9e+00
cases:1.12%
controls:0.11%
—
—
—
—
—
—
—
—
cases:1.40%
controls:0.00%
cases:2.90%
controls:0.16%
5
5
442
4460
—
—
—
—
6
0
424
4413
10
6
335
3692
Iron deficiency anaemia secondary to blood loss (chronic)
D50.0 [45566697]
—
2.9e+00
—
—
—
1.9e+00
—
—
—
cases:2.01%
controls:0.11%
—
—
—
—
—
—
cases:1.16%
controls:0.18%
—
—
—
9
5
438
4460
—
—
—
5
8
425
4405
—
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
6.3e-01
-1.0e+50
—
1.0e+50
—
1.9e+00
1.0e+00
cases:1.34%
controls:0.72%
cases:0.00%
controls:0.34%
—
—
cases:3.36%
controls:0.00%
—
—
cases:3.49%
controls:0.54%
cases:4.64%
controls:1.73%
6
32
441
4433
0
15
447
4450
—
15
0
432
4465
—
15
24
415
4389
16
64
329
3634
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
4.0e-02
—
—
1.0e+50
—
2.0e+00
8.5e-01
cases:1.12%
controls:1.08%
—
—
—
—
cases:4.70%
controls:0.00%
—
—
cases:4.42%
controls:0.61%
cases:6.09%
controls:2.70%
5
48
442
4417
—
—
21
0
426
4465
—
19
27
411
4386
21
100
324
3598
Human epididymis protein 4 [Moles/volume] in Serum or Plasma
55180-4 [40758310]
—
2.8e+00
—
—
—
—
—
—
—
cases:2.24%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
10
6
437
4459
—
—
—
—
—
Cytology report of Tissue fine needle aspirate Cyto stain
33718-8 [3043109]
-1.0e+50
2.8e+00
—
—
—
—
—
cases:0.00%
controls:0.27%
cases:1.79%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
0
12
447
4453
8
5
439
4460
—
—
—
—
—
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
4.1e-01
9.0e-01
—
—
—
1.6e+00
1.1e+00
cases:4.03%
controls:2.71%
cases:2.01%
controls:0.83%
—
—
—
—
—
—
cases:3.02%
controls:0.61%
cases:6.67%
controls:2.27%
18
121
429
4344
9
37
438
4428
—
—
—
13
27
417
4386
23
84
322
3614
ECG with 12 standard connections
XF400 [2001303368]
2.3e-01
8.5e-01
—
—
—
1.8e+00
9.3e-01
cases:3.13%
controls:2.51%
cases:1.57%
controls:0.67%
—
—
—
—
—
—
cases:2.33%
controls:0.41%
cases:4.93%
controls:2.00%
14
112
433
4353
7
30
440
4435
—
—
—
10
18
420
4395
17
74
328
3624
Plastic And Reconstructive Surgery
24 [38004467]
8.5e-01
1.4e+00
—
—
—
1.6e+00
1.1e+00
cases:4.47%
controls:1.97%
cases:2.24%
controls:0.58%
—
—
—
—
—
—
cases:2.79%
controls:0.57%
cases:5.51%
controls:1.97%
20
88
427
4377
10
26
437
4439
—
—
—
12
25
418
4388
19
73
326
3625
Flexible sigmoidoscopy with biopsy
UJF45 [2001305031]
—
—
—
—
—
2.7e+00
1.6e+00
—
—
—
—
—
—
—
—
—
—
cases:1.63%
controls:0.11%
cases:2.03%
controls:0.43%
—
—
—
—
—
7
5
423
4408
7
16
338
3682
Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
19176-7 [3015916]
—
2.3e+00
1.0e+50
—
—
2.7e+00
1.9e+00
—
—
cases:1.12%
controls:0.11%
cases:1.57%
controls:0.00%
—
—
—
—
cases:1.63%
controls:0.11%
cases:1.74%
controls:0.27%
—
5
5
442
4460
7
0
440
4465
—
—
7
5
423
4408
6
10
339
3688
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
—
—
1.0e+50
—
1.0e+50
2.6e+00
9.5e-01
—
—
—
—
cases:1.79%
controls:0.00%
—
—
cases:1.14%
controls:0.00%
cases:1.86%
controls:0.14%
cases:1.45%
controls:0.57%
—
—
8
0
439
4465
—
5
0
434
4464
8
6
422
4407
5
21
340
3677
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
6.6e-01
1.0e+00
—
1.0e+50
—
1.6e+00
1.0e+00
cases:2.91%
controls:1.52%
cases:1.57%
controls:0.58%
—
—
cases:1.12%
controls:0.00%
—
—
cases:2.79%
controls:0.59%
cases:4.93%
controls:1.78%
13
68
434
4397
7
26
440
4439
—
5
0
442
4465
—
12
26
418
4387
17
66
328
3632
Biopsy of prostate with ultrasoudnguidance
KE1AT [2001306172]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.74%
controls:0.14%
—
—
—
—
—
—
6
5
339
3693
Cathetrisation of artery
TPH07 [2001309747]
5.6e-01
1.4e+00
1.0e+50
1.0e+50
—
2.6e+00
7.7e-01
cases:1.79%
controls:1.03%
cases:1.34%
controls:0.34%
cases:4.25%
controls:0.00%
cases:5.15%
controls:0.00%
—
—
cases:5.35%
controls:0.43%
cases:3.77%
controls:1.78%
8
46
439
4419
6
15
441
4450
19
0
428
4465
23
0
424
4465
—
23
19
407
4394
13
66
332
3632
tinzaparin; parenteral
B01AB10 [21600981]
8.3e-01
1.4e+00
—
—
1.0e+50
2.5e+00
5.9e-01
cases:1.12%
controls:0.49%
cases:1.57%
controls:0.38%
—
—
—
—
cases:5.47%
controls:0.00%
cases:4.42%
controls:0.36%
cases:2.32%
controls:1.30%
5
22
442
4443
7
17
440
4448
—
—
24
0
415
4464
19
16
411
4397
8
48
337
3650
lansoprazole; oral
A02BC03 [21600098]
1.3e-01
6.3e-01
1.1e+00
—
1.6e+00
8.9e-01
3.0e-01
cases:5.37%
controls:4.75%
cases:4.25%
controls:2.31%
cases:1.12%
controls:0.38%
—
—
cases:1.82%
controls:0.36%
cases:4.65%
controls:1.97%
cases:4.93%
controls:3.70%
24
212
423
4253
19
103
428
4362
5
17
442
4448
—
8
16
431
4448
20
87
410
4326
17
137
328
3561
Blood transfusion
WW500 [2001310603]
—
—
1.0e+50
—
—
—
2.5e+00
—
—
—
—
cases:1.12%
controls:0.00%
—
—
—
—
—
—
cases:2.32%
controls:0.19%
—
—
5
0
442
4465
—
—
—
8
7
337
3691
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
8.6e-01
6.2e-01
—
—
—
1.3e+00
1.2e+00
cases:2.91%
controls:1.25%
cases:1.12%
controls:0.60%
—
—
—
—
—
—
cases:2.79%
controls:0.75%
cases:7.25%
controls:2.33%
13
56
434
4409
5
27
442
4438
—
—
—
12
33
418
4380
25
86
320
3612
Creatine kinase.MB [Mass/volume] in Serum or Plasma
13969-1 [3005785]
-7.9e-01
-3.4e-01
—
—
2.5e+00
7.6e-01
4.6e-01
cases:1.12%
controls:2.44%
cases:1.12%
controls:1.57%
—
—
—
—
cases:1.37%
controls:0.11%
cases:1.63%
controls:0.77%
cases:5.51%
controls:3.54%
5
109
442
4356
5
70
442
4395
—
—
6
5
433
4459
7
34
423
4379
19
131
326
3567
Colonoscopy Study observation
28023-0 [3022145]
4.5e-01
1.5e+00
—
—
—
1.1e+00
9.7e-01
cases:2.91%
controls:1.88%
cases:2.91%
controls:0.65%
—
—
—
—
—
—
cases:2.09%
controls:0.73%
cases:7.83%
controls:3.11%
13
84
434
4381
13
29
434
4436
—
—
—
9
32
421
4381
27
115
318
3583
SMOKING - SMOKE2: no - SMOKE3: never - SMOKE5: Unspecified
SMOKING-2-3-0 [2002330113]
-8.4e-01
-6.4e-01
2.5e+00
—
1.0e+50
1.0e+50
1.0e+50
cases:3.13%
controls:6.97%
cases:1.34%
controls:2.51%
cases:1.79%
controls:0.16%
—
—
cases:1.14%
controls:0.00%
cases:2.09%
controls:0.00%
cases:5.51%
controls:0.00%
14
311
433
4154
6
112
441
4353
8
7
439
4458
—
5
0
434
4464
9
0
421
4413
19
0
326
3698
Prostate Pathology biopsy report
66117-3 [40768800]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.45%
controls:0.14%
—
—
—
—
—
—
5
5
340
3693
cefalexin; oral
J01DB01 [21602870]
1.2e-01
6.4e-01
1.2e+00
—
1.7e+00
4.9e-01
3.7e-01
cases:30.43%
controls:27.93%
cases:13.87%
controls:7.82%
cases:2.24%
controls:0.72%
—
—
cases:4.10%
controls:0.76%
cases:12.79%
controls:8.27%
cases:29.57%
controls:22.53%
136
1247
311
3218
62
349
385
4116
10
32
437
4433
—
18
34
421
4430
55
365
375
4048
102
833
243
2865
Hematology
82 [38004501]
1.4e+00
1.7e+00
—
—
—
2.3e+00
1.4e+00
cases:1.57%
controls:0.38%
cases:1.57%
controls:0.29%
—
—
—
—
—
—
cases:1.86%
controls:0.18%
cases:2.32%
controls:0.59%
7
17
440
4448
7
13
440
4452
—
—
—
8
8
422
4405
8
22
337
3676
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
—
—
1.0e+50
—
1.0e+50
2.3e+00
1.2e+00
—
—
—
—
cases:1.57%
controls:0.00%
—
—
cases:1.14%
controls:0.00%
cases:1.40%
controls:0.14%
cases:2.03%
controls:0.62%
—
—
7
0
440
4465
—
5
0
434
4464
6
6
424
4407
7
23
338
3675
Dietary counselling and surveillance
Z71.3 [45552101]
—
—
—
—
—
2.3e+00
1.3e+00
—
—
—
—
—
—
—
—
—
—
cases:1.16%
controls:0.11%
cases:2.03%
controls:0.54%
—
—
—
—
—
5
5
425
4408
7
20
338
3678
Procedure duration 60 to 89 minutes
ZXE11 [2001311402]
4.5e-01
—
—
—
—
2.3e+00
—
cases:1.12%
controls:0.72%
—
—
—
—
—
—
—
—
cases:1.16%
controls:0.11%
—
—
5
32
442
4433
—
—
—
—
5
5
425
4408
—
Lumbar epidural anesthesia
WX306 [2001310796]
—
-1.0e+50
1.0e+50
—
—
2.3e+00
—
—
—
cases:0.00%
controls:0.13%
cases:1.34%
controls:0.00%
—
—
—
—
cases:1.16%
controls:0.11%
—
—
—
0
6
447
4459
6
0
441
4465
—
—
5
5
425
4408
—
Ileoscopy through colon
UJF30 [2001305028]
3.5e-01
2.2e+00
—
—
—
—
8.8e-01
cases:2.01%
controls:1.43%
cases:2.68%
controls:0.29%
—
—
—
—
—
—
—
—
cases:3.77%
controls:1.60%
9
64
438
4401
12
13
435
4452
—
—
—
—
13
59
332
3639
Neck ultrasound examination
EP1AE [2001302284]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.61%
controls:0.30%
—
—
—
—
—
—
9
11
336
3687
Hemoglobin A1c/Hemoglobin.total in Blood
4548-4 [3004410]
2.9e-02
2.3e-01
1.4e+00
-1.0e+50
8.2e-01
-2.8e-02
-2.2e-01
cases:33.78%
controls:33.12%
cases:30.43%
controls:25.71%
cases:12.75%
controls:3.58%
cases:0.00%
controls:0.13%
cases:7.74%
controls:3.56%
cases:26.51%
controls:27.06%
cases:49.86%
controls:55.44%
151
1479
296
2986
136
1148
311
3317
57
160
390
4305
0
6
447
4459
34
159
405
4305
114
1194
316
3219
172
2050
173
1648
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]
—
—
1.0e+50
—
—
2.2e+00
1.3e+00
—
—
—
—
cases:1.57%
controls:0.00%
—
—
—
—
cases:1.40%
controls:0.16%
cases:2.32%
controls:0.62%
—
—
7
0
440
4465
—
—
6
7
424
4406
8
23
337
3675
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
1.0e+00
—
—
—
—
2.2e+00
8.3e-01
cases:2.46%
controls:0.90%
—
—
—
—
—
—
—
—
cases:2.33%
controls:0.27%
cases:2.03%
controls:0.89%
11
40
436
4425
—
—
—
—
10
12
420
4401
7
33
338
3665
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
3.9e-01
—
—
1.0e+50
—
2.2e+00
5.7e-01
cases:1.12%
controls:0.76%
—
—
—
—
cases:4.03%
controls:0.00%
—
—
cases:3.26%
controls:0.39%
cases:3.77%
controls:2.16%
5
34
442
4431
—
—
18
0
429
4465
—
14
17
416
4396
13
80
332
3618
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
5.4e-01
2.2e+00
—
—
—
6.1e-01
9.0e-01
cases:3.80%
controls:2.26%
cases:3.58%
controls:0.43%
—
—
—
—
—
—
cases:1.16%
controls:0.63%
cases:3.77%
controls:1.57%
17
101
430
4364
16
19
431
4446
—
—
—
5
28
425
4385
13
58
332
3640
FEV1 percent change
69983-5 [42868472]
5.4e-01
2.2e+00
—
—
—
6.1e-01
9.0e-01
cases:3.80%
controls:2.26%
cases:3.58%
controls:0.43%
—
—
—
—
—
—
cases:1.16%
controls:0.63%
cases:3.77%
controls:1.57%
17
101
430
4364
16
19
431
4446
—
—
—
5
28
425
4385
13
58
332
3640
FEV1 --post bronchodilation
20155-8 [3023550]
5.4e-01
2.2e+00
—
—
—
6.1e-01
9.0e-01
cases:3.80%
controls:2.26%
cases:3.58%
controls:0.43%
—
—
—
—
—
—
cases:1.16%
controls:0.63%
cases:3.77%
controls:1.57%
17
101
430
4364
16
19
431
4446
—
—
—
5
28
425
4385
13
58
332
3640
FEV1/FVC --post bronchodilation
69970-2 [42868459]
5.4e-01
2.2e+00
—
—
—
6.1e-01
9.0e-01
cases:3.80%
controls:2.26%
cases:3.58%
controls:0.43%
—
—
—
—
—
—
cases:1.16%
controls:0.63%
cases:3.77%
controls:1.57%
17
101
430
4364
16
19
431
4446
—
—
—
5
28
425
4385
13
58
332
3640
FVC percent change Respiratory system
69982-7 [42868471]
5.4e-01
2.2e+00
—
—
—
6.1e-01
9.0e-01
cases:3.80%
controls:2.26%
cases:3.58%
controls:0.43%
—
—
—
—
—
—
cases:1.16%
controls:0.63%
cases:3.77%
controls:1.57%
17
101
430
4364
16
19
431
4446
—
—
—
5
28
425
4385
13
58
332
3640
Constipation, unspecified
K59.09 [2000502926]
—
2.2e+00
—
—
—
—
6.4e-01
—
—
cases:1.34%
controls:0.16%
—
—
—
—
—
—
—
—
cases:2.03%
controls:1.08%
—
6
7
441
4458
—
—
—
—
7
40
338
3658
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
4.2e-01
6.3e-01
2.1e+00
—
1.5e+00
6.5e-01
4.8e-01
cases:4.92%
controls:3.29%
cases:4.03%
controls:2.19%
cases:2.24%
controls:0.27%
—
—
cases:1.14%
controls:0.25%
cases:5.81%
controls:3.13%
cases:15.94%
controls:10.49%
22
147
425
4318
18
98
429
4367
10
12
437
4453
—
5
11
434
4453
25
138
405
4275
55
388
290
3310
Palliative care
Z51.5 [45547323]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.06%
controls:0.51%
—
—
—
—
—
—
14
19
331
3679
Metanephrine Free [Moles/volume] in Serum or Plasma
49700-8 [3032155]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.90%
controls:0.38%
—
—
—
—
—
—
10
14
335
3684
Other and unspecified ventral hernia without obstruction or gangrene
K43.9 [45533594]
—
—
—
—
—
2.0e+00
2.1e+00
—
—
—
—
—
—
—
—
—
—
cases:1.16%
controls:0.16%
cases:2.90%
controls:0.38%
—
—
—
—
—
5
7
425
4406
10
14
335
3684
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
1.7e-01
6.0e-01
1.4e+00
—
8.1e-01
6.3e-01
2.9e-01
cases:8.72%
controls:7.48%
cases:7.61%
controls:4.32%
cases:2.46%
controls:0.60%
—
—
cases:1.59%
controls:0.72%
cases:8.60%
controls:4.78%
cases:18.84%
controls:14.74%
39
334
408
4131
34
193
413
4272
11
27
436
4438
—
7
32
432
4432
37
211
393
4202
65
545
280
3153
FEV1
20150-9 [3024653]
4.1e-01
2.0e+00
—
—
—
4.5e-01
7.8e-01
cases:3.80%
controls:2.55%
cases:4.03%
controls:0.54%
—
—
—
—
—
—
cases:1.16%
controls:0.75%
cases:3.77%
controls:1.76%
17
114
430
4351
18
24
429
4441
—
—
—
5
33
425
4380
13
65
332
3633
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
4.1e-01
2.0e+00
—
—
—
4.5e-01
7.8e-01
cases:3.80%
controls:2.55%
cases:4.03%
controls:0.54%
—
—
—
—
—
—
cases:1.16%
controls:0.75%
cases:3.77%
controls:1.76%
17
114
430
4351
18
24
429
4441
—
—
—
5
33
425
4380
13
65
332
3633
FEV1/FVC
19926-5 [3011505]
4.1e-01
2.0e+00
—
—
—
4.5e-01
7.8e-01
cases:3.80%
controls:2.55%
cases:4.03%
controls:0.54%
—
—
—
—
—
—
cases:1.16%
controls:0.75%
cases:3.77%
controls:1.76%
17
114
430
4351
18
24
429
4441
—
—
—
5
33
425
4380
13
65
332
3633
pneumococcus, purified polysaccharides antigen
J07AL01 [21601312]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.03%
controls:0.27%
—
—
—
—
—
—
7
10
338
3688
Examination and observation for other specified reasons
Z04.8 [45552063]
1.9e-01
2.0e+00
—
—
—
1.4e+00
3.6e-01
cases:2.24%
controls:1.86%
cases:4.25%
controls:0.58%
—
—
—
—
—
—
cases:1.86%
controls:0.48%
cases:3.19%
controls:2.24%
10
83
437
4382
19
26
428
4439
—
—
—
8
21
422
4392
11
83
334
3615
Normetanephrine [Moles/volume] in Serum or Plasma
25489-6 [3026179]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.90%
controls:0.41%
—
—
—
—
—
—
10
15
335
3683
3-Methoxytyramine [Moles/volume] in Serum or Plasma
50140-3 [3030408]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.90%
controls:0.41%
—
—
—
—
—
—
10
15
335
3683
Metanephrine [Moles/volume] in Serum or Plasma
25473-0 [3009340]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.32%
controls:0.32%
—
—
—
—
—
—
8
12
337
3686
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
—
—
—
—
—
2.0e+00
1.2e+00
—
—
—
—
—
—
—
—
—
—
cases:1.63%
controls:0.23%
cases:2.90%
controls:0.89%
—
—
—
—
—
7
10
423
4403
10
33
335
3665
esomeprazole; oral, parenteral
A02BC05 [21600100]
1.7e-01
6.2e-01
8.1e-01
—
1.4e+00
5.2e-01
5.0e-01
cases:10.96%
controls:9.43%
cases:9.17%
controls:5.15%
cases:3.13%
controls:1.41%
—
—
cases:3.64%
controls:0.96%
cases:8.37%
controls:5.17%
cases:13.33%
controls:8.52%
49
421
398
4044
41
230
406
4235
14
63
433
4402
—
16
43
423
4421
36
228
394
4185
46
315
299
3383
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
2.2e-01
—
—
1.0e+50
—
2.0e+00
8.1e-01
cases:1.34%
controls:1.08%
—
—
—
—
cases:5.15%
controls:0.00%
—
—
cases:4.19%
controls:0.61%
cases:5.80%
controls:2.68%
6
48
441
4417
—
—
23
0
424
4465
—
18
27
412
4386
20
99
325
3599
Cerebral infarction due to embolism of cerebral arteries
I63.4 [45591475]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.03%
controls:0.30%
—
—
—
—
—
—
7
11
338
3687
Enzyme measurement
122444009 [4046263]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.32%
controls:0.35%
—
—
—
—
—
—
8
13
337
3685
Bloodpressure measurement
XF600 [2001303376]
—
-1.0e+50
—
—
—
—
1.9e+00
—
—
cases:0.00%
controls:0.34%
—
—
—
—
—
—
—
—
cases:3.77%
controls:0.59%
—
0
15
447
4450
—
—
—
—
13
22
332
3676
Obesity due to excess calories
E66.01 [2000501501]
7.3e-01
1.9e+00
—
—
—
1.2e+00
5.3e-01
cases:1.79%
controls:0.87%
cases:2.01%
controls:0.31%
—
—
—
—
—
—
cases:1.63%
controls:0.50%
cases:2.32%
controls:1.38%
8
39
439
4426
9
14
438
4451
—
—
—
7
22
423
4391
8
51
337
3647
Other specified counselling
Z71.8 [45581061]
3.4e-01
5.5e-01
1.8e+00
—
—
7.2e-01
3.1e-01
cases:5.37%
controls:3.90%
cases:3.36%
controls:1.97%
cases:2.24%
controls:0.36%
—
—
—
—
cases:5.35%
controls:2.67%
cases:13.04%
controls:9.87%
24
174
423
4291
15
88
432
4377
10
16
437
4449
—
—
23
118
407
4295
45
365
300
3333
Thorax extensive CT-examination
GD1BD [2001303621]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.03%
controls:0.32%
—
—
—
—
—
—
7
12
338
3686
Abdominal X-ray examination without contrast
JN3AA [2001305553]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.32%
controls:0.38%
—
—
—
—
—
—
8
14
337
3684
Extensive structural and functional ultrasound examination of heart
FM1EE [2001303307]
2.1e-01
2.8e-01
1.8e+00
—
-1.0e+50
5.0e-01
5.1e-01
cases:6.49%
controls:5.33%
cases:3.13%
controls:2.37%
cases:1.79%
controls:0.29%
—
—
cases:0.00%
controls:0.11%
cases:3.49%
controls:2.15%
cases:10.43%
controls:6.54%
29
238
418
4227
14
106
433
4359
8
13
439
4452
—
0
5
439
4459
15
95
415
4318
36
242
309
3456
Helicobacter pylori Ag [Presence] in Stool
31843-6 [3013139]
3.3e-01
1.8e+00
—
—
—
—
1.9e-01
cases:2.24%
controls:1.61%
cases:2.46%
controls:0.40%
—
—
—
—
—
—
—
—
cases:2.32%
controls:1.92%
10
72
437
4393
11
18
436
4447
—
—
—
—
8
71
337
3627
clarithromycin; oral, parenteral
J01FA09 [21602977]
4.3e-01
1.8e+00
—
—
—
1.2e+00
1.1e-02
cases:2.91%
controls:1.90%
cases:1.57%
controls:0.27%
—
—
—
—
—
—
cases:1.40%
controls:0.41%
cases:1.45%
controls:1.43%
13
85
434
4380
7
12
440
4453
—
—
—
6
18
424
4395
5
53
340
3645
Unspecified haematuria
R31 [45553726]
9.3e-01
1.8e+00
—
—
—
1.6e+00
8.2e-01
cases:3.13%
controls:1.25%
cases:2.68%
controls:0.47%
—
—
—
—
—
—
cases:1.63%
controls:0.32%
cases:3.77%
controls:1.70%
14
56
433
4409
12
21
435
4444
—
—
—
7
14
423
4399
13
63
332
3635
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
-1.2e-01
3.1e-01
1.7e+00
—
—
-7.6e-01
2.3e-01
cases:6.71%
controls:7.50%
cases:4.92%
controls:3.67%
cases:2.24%
controls:0.40%
—
—
—
—
cases:1.86%
controls:3.90%
cases:14.20%
controls:11.63%
30
335
417
4130
22
164
425
4301
10
18
437
4447
—
—
8
172
422
4241
49
430
296
3268
Asthma, unspecified
J45.9 [45562456]
1.7e-01
4.9e-01
1.7e+00
—
1.2e+00
2.9e-01
-5.5e-02
cases:4.92%
controls:4.17%
cases:3.13%
controls:1.95%
cases:1.79%
controls:0.34%
—
—
cases:1.14%
controls:0.36%
cases:2.79%
controls:2.11%
cases:4.93%
controls:5.19%
22
186
425
4279
14
87
433
4378
8
15
439
4450
—
5
16
434
4448
12
93
418
4320
17
192
328
3506
magnesium hydroxide; oral
A02AA04 [21600052]
—
—
—
—
—
1.6e+00
8.0e-01
—
—
—
—
—
—
—
—
—
—
cases:1.86%
controls:0.36%
cases:2.03%
controls:0.92%
—
—
—
—
—
8
16
422
4397
7
34
338
3664
magnesium hydroxide; oral
G04BX01 [21602658]
—
—
—
—
—
1.6e+00
8.0e-01
—
—
—
—
—
—
—
—
—
—
cases:1.86%
controls:0.36%
cases:2.03%
controls:0.92%
—
—
—
—
—
8
16
422
4397
7
34
338
3664
Hemolysis interference index of Serum or Plasma
46424-8 [3052851]
8.6e-01
—
—
—
—
1.7e+00
1.6e+00
cases:1.79%
controls:0.76%
—
—
—
—
—
—
—
—
cases:1.40%
controls:0.25%
cases:2.61%
controls:0.51%
8
34
439
4431
—
—
—
—
6
11
424
4402
9
19
336
3679
Pure hypercholesterolaemia
E78.01 [2000501514]
-5.6e-03
5.6e-02
—
1.0e+50
1.6e+00
5.1e-01
-5.8e-01
cases:5.37%
controls:5.40%
cases:2.46%
controls:2.33%
—
—
cases:2.24%
controls:0.00%
cases:2.05%
controls:0.40%
cases:4.42%
controls:2.70%
cases:4.93%
controls:8.46%
24
241
423
4224
11
104
436
4361
—
10
0
437
4465
9
18
430
4446
19
119
411
4294
17
313
328
3385
Bacterial infection, unspecified
A49.9 [45590816]
2.5e-01
1.0e+00
—
—
—
1.6e+00
3.4e-01
cases:1.34%
controls:1.05%
cases:1.34%
controls:0.49%
—
—
—
—
—
—
cases:2.33%
controls:0.48%
cases:2.90%
controls:2.08%
6
47
441
4418
6
22
441
4443
—
—
—
10
21
420
4392
10
77
335
3621
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
—
-1.0e+50
—
—
—
—
1.6e+00
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
—
—
cases:4.64%
controls:1.00%
—
0
21
447
4444
—
—
—
—
16
37
329
3661
clidinium and psycholeptics
A03CA02 [21600204]
5.4e-01
—
—
—
—
9.0e-01
1.6e+00
cases:2.01%
controls:1.19%
—
—
—
—
—
—
—
—
cases:1.16%
controls:0.48%
cases:3.48%
controls:0.76%
9
53
438
4412
—
—
—
—
5
21
425
4392
12
28
333
3670
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
5.6e-02
3.6e-01
1.5e+00
—
4.0e-01
-6.3e-02
9.7e-02
cases:23.71%
controls:22.71%
cases:17.45%
controls:12.86%
cases:6.94%
controls:1.59%
—
—
cases:2.28%
controls:1.55%
cases:12.09%
controls:12.78%
cases:34.49%
controls:32.34%
106
1014
341
3451
78
574
369
3891
31
71
416
4394
—
10
69
429
4395
52
564
378
3849
119
1196
226
2502
furosemide; oral, parenteral
C03CA01 [21601518]
2.3e-01
3.6e-01
2.0e-01
—
1.4e-01
8.3e-01
6.9e-01
cases:9.84%
controls:7.97%
cases:9.40%
controls:6.72%
cases:2.68%
controls:2.22%
—
—
cases:2.73%
controls:2.37%
cases:15.58%
controls:7.43%
cases:20.58%
controls:11.47%
44
356
403
4109
42
300
405
4165
12
99
435
4366
—
12
106
427
4358
67
328
363
4085
71
424
274
3274
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
LC2BE [2001306544]
-4.4e-01
1.5e+00
—
—
—
7.3e-01
4.6e-02
cases:1.79%
controls:2.75%
cases:2.46%
controls:0.56%
—
—
—
—
—
—
cases:1.40%
controls:0.68%
cases:2.32%
controls:2.22%
8
123
439
4342
11
25
436
4440
—
—
—
6
30
424
4383
8
82
337
3616
Atherosclerotic heart disease
I25.1 [45596196]
-1.8e-01
-6.6e-02
1.5e+00
—
1.0e+00
4.3e-01
2.0e-01
cases:6.26%
controls:7.39%
cases:3.80%
controls:4.05%
cases:2.91%
controls:0.69%
—
—
cases:2.05%
controls:0.76%
cases:6.05%
controls:4.01%
cases:11.59%
controls:9.65%
28
330
419
4135
17
181
430
4284
13
31
434
4434
—
9
34
430
4430
26
177
404
4236
40
357
305
3341
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
-2.0e-01
2.6e-01
1.4e+00
—
5.8e-01
5.8e-02
-2.5e-02
cases:10.29%
controls:12.34%
cases:9.62%
controls:7.59%
cases:3.80%
controls:0.99%
—
—
cases:1.82%
controls:1.03%
cases:8.84%
controls:8.38%
cases:23.48%
controls:23.93%
46
551
401
3914
43
339
404
4126
17
44
430
4421
—
8
46
431
4418
38
370
392
4043
81
885
264
2813
Sedation and analgesia
WX002 [2001310758]
1.7e-01
9.7e-01
—
—
—
1.4e+00
5.2e-01
cases:4.03%
controls:3.43%
cases:2.68%
controls:1.03%
—
—
—
—
—
—
cases:2.56%
controls:0.66%
cases:4.06%
controls:2.46%
18
153
429
4312
12
46
435
4419
—
—
—
11
29
419
4384
14
91
331
3607
ibuprofen
R02AX02 [1588667]
1.4e-01
1.4e-01
3.0e-01
—
1.4e+00
2.7e-01
3.1e-01
cases:37.81%
controls:34.47%
cases:15.88%
controls:14.06%
cases:2.91%
controls:2.17%
—
—
cases:7.06%
controls:1.88%
cases:17.91%
controls:14.32%
cases:36.52%
controls:29.61%
169
1539
278
2926
71
628
376
3837
13
97
434
4368
—
31
84
408
4380
77
632
353
3781
126
1095
219
2603
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
1.4e-01
1.4e-01
3.0e-01
—
1.4e+00
2.7e-01
3.1e-01
cases:37.81%
controls:34.47%
cases:15.88%
controls:14.06%
cases:2.91%
controls:2.17%
—
—
cases:7.06%
controls:1.88%
cases:17.91%
controls:14.32%
cases:36.52%
controls:29.61%
169
1539
278
2926
71
628
376
3837
13
97
434
4368
—
31
84
408
4380
77
632
353
3781
126
1095
219
2603
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
-1.6e-01
2.4e-01
1.3e+00
—
5.3e-01
2.3e-02
2.8e-01
cases:6.49%
controls:7.50%
cases:6.04%
controls:4.79%
cases:2.46%
controls:0.65%
—
—
cases:1.14%
controls:0.67%
cases:5.12%
controls:5.01%
cases:16.81%
controls:13.22%
29
335
418
4130
27
214
420
4251
11
29
436
4436
—
5
30
434
4434
22
221
408
4192
58
489
287
3209
Tissue transglutaminase IgA Ab [Units/volume] in Serum
31017-7 [3019050]
2.9e-01
1.3e+00
—
—
—
1.1e-01
-3.2e-02
cases:5.15%
controls:3.90%
cases:4.25%
controls:1.16%
—
—
—
—
—
—
cases:1.86%
controls:1.68%
cases:5.80%
controls:5.98%
23
174
424
4291
19
52
428
4413
—
—
—
8
74
422
4339
20
221
325
3477
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
-2.1e-01
2.7e-01
1.3e+00
—
7.0e-01
8.6e-02
4.7e-02
cases:10.07%
controls:12.09%
cases:9.62%
controls:7.53%
cases:3.58%
controls:0.99%
—
—
cases:2.05%
controls:1.03%
cases:9.07%
controls:8.38%
cases:24.64%
controls:23.77%
45
540
402
3925
43
336
404
4129
16
44
431
4421
—
9
46
430
4418
39
370
391
4043
85
879
260
2819
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
-2.6e-01
2.4e-01
1.3e+00
—
5.6e-01
8.4e-02
1.2e-02
cases:9.17%
controls:11.62%
cases:9.17%
controls:7.35%
cases:3.58%
controls:0.99%
—
—
cases:1.82%
controls:1.05%
cases:8.84%
controls:8.18%
cases:23.77%
controls:23.55%
41
519
406
3946
41
328
406
4137
16
44
431
4421
—
8
47
431
4417
38
361
392
4052
82
871
263
2827
Nausea and vomiting
R11 [45539317]
-1.1e-03
—
—
—
—
—
1.3e+00
cases:1.12%
controls:1.12%
—
—
—
—
—
—
—
—
—
—
cases:3.77%
controls:1.08%
5
50
442
4415
—
—
—
—
—
13
40
332
3658
Cardiology
6 [38004451]
9.2e-02
3.1e-01
1.3e+00
—
5.2e-01
3.8e-01
3.6e-01
cases:16.55%
controls:15.32%
cases:11.19%
controls:8.47%
cases:4.70%
controls:1.39%
—
—
cases:2.05%
controls:1.23%
cases:10.47%
controls:7.43%
cases:23.48%
controls:17.66%
74
684
373
3781
50
378
397
4087
21
62
426
4403
—
9
55
430
4409
45
328
385
4085
81
653
264
3045
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
-3.5e-01
1.4e-01
1.2e+00
—
2.2e-01
-9.3e-02
-9.5e-02
cases:7.83%
controls:10.80%
cases:7.38%
controls:6.47%
cases:2.68%
controls:0.78%
—
—
cases:1.14%
controls:0.92%
cases:6.05%
controls:6.59%
cases:17.10%
controls:18.50%
35
482
412
3983
33
289
414
4176
12
35
435
4430
—
5
41
434
4423
26
291
404
4122
59
684
286
3014
Other specified special examinations
Z01.8 [45581003]
-1.1e-01
1.2e+00
—
—
—
—
4.1e-01
cases:3.13%
controls:3.47%
cases:3.36%
controls:0.99%
—
—
—
—
—
—
—
—
cases:5.80%
controls:3.92%
14
155
433
4310
15
44
432
4421
—
—
—
—
20
145
325
3553
Infiltration anesthesia
WX110 [2001310767]
3.8e-03
2.4e-01
1.2e+00
1.0e+50
1.0e+00
4.3e-01
3.6e-01
cases:21.92%
controls:21.86%
cases:10.07%
controls:8.09%
cases:3.36%
controls:1.01%
cases:8.28%
controls:0.00%
cases:2.28%
controls:0.85%
cases:11.86%
controls:8.07%
cases:29.28%
controls:22.39%
98
976
349
3489
45
361
402
4104
15
45
432
4420
37
0
410
4465
10
38
429
4426
51
356
379
4057
101
828
244
2870
Abdominal pain/cramps general
D01 [2002000300]
2.3e-01
1.6e+00
—
—
—
1.2e+00
1.2e+00
cases:1.57%
controls:1.25%
cases:1.57%
controls:0.31%
—
—
—
—
—
—
cases:1.16%
controls:0.36%
cases:4.64%
controls:1.46%
7
56
440
4409
7
14
440
4451
—
—
—
5
16
425
4397
16
54
329
3644
Standard cardiac ultrasound examination
FM1AE [2001303278]
4.9e-02
1.2e+00
1.3e+00
—
-1.0e+50
6.5e-01
6.6e-01
cases:4.25%
controls:4.05%
cases:4.92%
controls:1.59%
cases:1.12%
controls:0.31%
—
—
cases:0.00%
controls:0.18%
cases:2.79%
controls:1.47%
cases:7.25%
controls:3.89%
19
181
428
4284
22
71
425
4394
5
14
442
4451
—
0
8
439
4456
12
65
418
4348
25
144
320
3554
Uroflowmetry
44856007 [4261340]
3.4e-01
1.2e+00
-1.0e+50
—
—
8.7e-01
6.4e-01
cases:4.03%
controls:2.91%
cases:3.13%
controls:1.01%
cases:0.00%
controls:0.13%
—
—
—
—
cases:2.09%
controls:0.88%
cases:4.93%
controls:2.65%
18
130
429
4335
14
45
433
4420
0
6
447
4459
—
—
9
39
421
4374
17
98
328
3600
calcium (different salts in combination); oral
A12AA20 [21600872]
6.0e-02
7.4e-02
3.8e-01
—
4.3e-01
5.1e-01
6.3e-01
cases:11.41%
controls:10.82%
cases:8.72%
controls:8.15%
cases:3.13%
controls:2.17%
—
—
cases:3.19%
controls:2.11%
cases:13.95%
controls:8.91%
cases:20.29%
controls:11.98%
51
483
396
3982
39
364
408
4101
14
97
433
4368
—
14
94
425
4370
60
393
370
4020
70
443
275
3255
Bacteria identified in Isolate by Culture
43409-2 [3042936]
2.2e-01
-1.1e-03
—
1.0e+50
—
1.1e+00
3.1e-01
cases:2.91%
controls:2.35%
cases:1.34%
controls:1.34%
—
—
cases:1.57%
controls:0.00%
—
—
cases:3.49%
controls:1.16%
cases:5.80%
controls:4.33%
13
105
434
4360
6
60
441
4405
—
7
0
440
4465
—
15
51
415
4362
20
160
325
3538
azithromycin; oral, parenteral
J01FA10 [21602978]
9.3e-02
1.1e+00
—
—
—
2.2e-01
7.2e-01
cases:7.16%
controls:6.56%
cases:3.36%
controls:1.12%
—
—
—
—
—
—
cases:1.63%
controls:1.31%
cases:6.96%
controls:3.52%
32
293
415
4172
15
50
432
4415
—
—
—
7
58
423
4355
24
130
321
3568
Atrial fibrillation and flutter
I48 [45596206]
7.2e-02
1.4e-01
1.1e+00
—
8.7e-01
3.4e-01
4.1e-01
cases:9.40%
controls:8.80%
cases:5.82%
controls:5.08%
cases:3.13%
controls:1.05%
—
—
cases:2.73%
controls:1.16%
cases:7.44%
controls:5.44%
cases:15.07%
controls:10.52%
42
393
405
4072
26
227
421
4238
14
47
433
4418
—
12
52
427
4412
32
240
398
4173
52
389
293
3309
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
-2.4e-01
6.1e-01
—
—
—
1.1e+00
6.0e-01
cases:4.92%
controls:6.18%
cases:3.58%
controls:1.97%
—
—
—
—
—
—
cases:4.42%
controls:1.52%
cases:10.14%
controls:5.81%
22
276
425
4189
16
88
431
4377
—
—
—
19
67
411
4346
35
215
310
3483
Other gastroenteritis and colitis of infectious and unspecified origin
A09 [45605189]
-1.2e-02
—
—
—
—
1.1e+00
1.1e+00
cases:2.01%
controls:2.04%
—
—
—
—
—
—
—
—
cases:1.63%
controls:0.54%
cases:7.25%
controls:2.57%
9
91
438
4374
—
—
—
—
7
24
423
4389
25
95
320
3603
Epistaxis
R04.0 [45606791]
1.1e+00
—
—
—
—
—
1.6e-01
cases:2.91%
controls:1.01%
—
—
—
—
—
—
—
—
—
—
cases:2.03%
controls:1.73%
13
45
434
4420
—
—
—
—
—
7
64
338
3634
Fasting glucose [Moles/volume] in Serum or Plasma
14771-0 [3018251]
4.3e-02
2.1e-01
1.0e+00
—
5.3e-01
-1.4e-01
-1.9e-01
cases:39.60%
controls:38.57%
cases:30.65%
controls:26.36%
cases:7.61%
controls:2.93%
—
—
cases:5.01%
controls:3.00%
cases:24.19%
controls:26.90%
cases:53.04%
controls:57.65%
177
1722
270
2743
137
1177
310
3288
34
131
413
4334
—
22
134
417
4330
104
1187
326
3226
183
2132
162
1566
Fever, unspecified
R50.9 [45582716]
6.0e-01
1.3e+00
—
—
—
1.3e+00
9.9e-01
cases:2.46%
controls:1.37%
cases:1.12%
controls:0.31%
—
—
—
—
—
—
cases:1.63%
controls:0.45%
cases:5.80%
controls:2.24%
11
61
436
4404
5
14
442
4451
—
—
—
7
20
423
4393
20
83
325
3615
hydrochlorothiazide; oral
C03AA03 [21601466]
-3.5e-01
-1.3e-01
—
—
—
9.7e-01
6.2e-01
cases:2.68%
controls:3.78%
cases:2.01%
controls:2.28%
—
—
—
—
—
—
cases:6.05%
controls:2.38%
cases:8.12%
controls:4.54%
12
169
435
4296
9
102
438
4363
—
—
—
26
105
404
4308
28
168
317
3530
metronidazole; oral, rectal
P01AB01 [21604857]
1.0e-01
9.6e-01
1.8e+00
—
1.7e+00
6.5e-01
3.7e-01
cases:7.16%
controls:6.52%
cases:4.47%
controls:1.77%
cases:1.12%
controls:0.18%
—
—
cases:1.14%
controls:0.20%
cases:2.33%
controls:1.22%
cases:6.38%
controls:4.49%
32
291
415
4174
20
79
427
4386
5
8
442
4457
—
5
9
434
4455
10
54
420
4359
22
166
323
3532
Heart failure, unspecified
I50.9 [45576879]
4.8e-01
4.8e-01
1.7e+00
—
—
9.4e-01
2.3e-01
cases:3.36%
controls:2.11%
cases:2.01%
controls:1.25%
cases:1.57%
controls:0.29%
—
—
—
—
cases:3.95%
controls:1.59%
cases:4.64%
controls:3.73%
15
94
432
4371
9
56
438
4409
7
13
440
4452
—
—
17
70
413
4343
16
138
329
3560

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
200
103
34.27
274.85
1.4
1.2
—
—
—
0
0
203
215
16.44
187.43
3.4
1.4
4.04
2.65
ug/l
0.69
156
164
115
85
17.86
128.52
2.8
1.6
234.27
72.67
u/ml
0.32
90
64
179
333
8.29
101.14
2.2
2.0
0.22
0.20
g/l
3.40
172
299
207
618
5.37
67.49
6.4
2.5
0.81
0.83
mmol/l
3.10
200
568
58
44
14.99
62.50
2.3
1.9
74.47
42.10
u/ml
0.21
47
38
351
1746
5.67
57.05
11.1
4.0
35.34
35.52
g/l
0.27
334
1623
128
303
5.51
53.40
1.4
1.1
—
—
—
0
0
272
1155
4.45
53.38
2.5
1.7
—
—
—
0
0
268
1136
4.38
52.48
3.4
2.1
—
—
—
0
0
331
1681
4.71
49.35
3.6
2.5
—
—
estimate
—
0
0
171
575
4.19
45.01
1.7
1.2
—
—
—
0
0
141
420
4.44
43.58
2.7
2.1
6.39
7.26
umol/l
0.29
130
371
166
607
3.76
37.77
8.2
6.3
105.45
104.30
mmol/l
2.84
166
607
338
1960
3.95
36.63
14.2
17.3
1.23
1.32
inr
2.15
281
1632
113
333
4.20
34.73
3.0
1.9
40.64
37.04
u/l
0.18
104
268
342
2047
3.83
34.18
15.9
5.9
3.81
4.27
e9/l
3.58
305
1755
260
1341
3.24
32.75
7.8
2.1
2.36
2.35
mmol/l
0.04
247
1172
317
1840
3.47
32.59
9.1
5.8
1.21
1.21
mmol/l
0.34
300
1665
160
638
3.35
30.88
2.6
2.6
2.33
2.25
g/l
1.05
154
588
110
347
3.88
30.43
5.7
1.6
64.11
67.02
g/l
4.12
103
318
336
2069
3.50
30.31
9.5
6.2
1.20
1.21
mmol/l
1.29
284
1785
166
697
3.19
29.12
2.7
2.6
11.84
13.05
umol/l
1.55
161
642
239
1236
3.00
28.87
5.5
5.2
—
—
—
0
0
149
596
3.25
28.26
2.5
2.6
19.99
23.48
%
2.82
142
549
410
2950
5.60
27.75
17.6
5.6
77.65
76.98
u/l
0.13
404
2740
231
1201
2.91
27.17
7.2
3.3
7.39
7.40
ph
2.25
176
855
204
1063
2.69
22.88
2.4
2.3
3.19
2.86
mg/l
0.93
178
905
228
1262
2.64
22.51
3.3
2.3
72.46
61.80
u/l
0.41
219
1160
175
853
2.73
22.31
6.0
2.1
2.47
2.45
mmol/l
0.91
168
756
276
1724
2.57
20.48
7.4
5.5
9.04
8.96
%
0.18
262
1608
274
1727
2.51
19.61
7.4
5.4
3.03
3.03
%
0.01
260
1610
201
1108
2.48
19.22
4.9
3.9
—
—
—
0
0
275
1751
2.48
19.03
7.4
5.5
27.06
26.79
%
0.15
265
1654
215
1237
2.42
18.52
7.2
2.7
30.56
34.05
u/l
0.84
209
1159
272
1737
2.44
18.49
7.5
5.4
0.68
0.70
%
0.38
258
1617
267
1702
2.41
18.07
19.0
10.0
0.00
0.00
e9/l
0.70
231
1399
296
1990
2.44
17.53
7.5
5.3
0.20
0.21
e9/l
0.17
259
1719
269
1738
2.37
17.39
7.4
5.4
57.68
57.97
%
0.15
257
1654
288
1924
2.39
17.13
7.5
5.2
0.58
0.60
e9/l
0.56
251
1633
288
1935
2.37
16.74
7.5
5.2
0.04
0.04
e9/l
0.73
251
1648
193
1097
2.33
16.65
11.9
4.3
—
—
—
0
0
289
1951
2.36
16.52
7.6
5.3
1.70
1.81
e9/l
1.57
257
1698
261
1713
2.25
15.60
3.5
3.0
125.34
132.30
ug/l
0.23
241
1584
193
1121
2.27
15.57
3.7
3.0
0.39
0.44
e6/l
0.21
148
812
189
1099
2.24
15.09
5.1
2.4
334.24
355.34
umol/l
2.15
169
940
213
1303
2.21
14.97
3.8
3.2
306.34
102.26
e6/l
0.44
170
989
90
380
2.71
14.52
9.0
7.6
—
—
—
0
0
229
1466
2.15
14.08
4.4
3.8
22.23
98.50
e6/l
4.70
173
1022
176
1051
2.11
12.63
3.8
3.0
—
0.00
estimate
—
0
8
108
532
2.36
12.44
7.5
6.9
0.08
1.08
mmol/l
1.91
97
447
108
537
2.33
12.15
7.8
7.0
7.42
7.42
ph
0.22
47
311
157
909
2.12
12.13
3.0
2.4
5.18
5.35
e6/l
0.08
145
826
102
505
2.32
11.54
2.0
2.1
1.85
1.74
%
0.46
88
446
71
299
2.63
11.38
3.4
2.6
1.23
1.22
mmol/l
0.54
65
247
88
411
2.42
11.35
1.4
1.3
—
—
—
0
0
85
392
2.44
11.27
2.0
2.3
64.93
66.54
e9/l
0.20
58
294
75
331
2.52
10.90
1.4
1.4
—
—
—
0
0
20
21
9.91
10.36
1.1
1.0
—
—
—
0
0
153
925
1.99
10.19
1.3
1.3
—
—
—
0
0
18
19
9.82
9.35
1.4
1.2
—
—
—
0
0
63
289
2.37
8.36
4.3
3.5
—
—
—
0
0
421
3730
3.14
8.35
29.8
14.7
30.22
24.83
mg/l
2.72
400
3019
113
658
1.96
8.14
1.7
1.7
29.40
29.72
s
0.28
107
635
319
2554
1.86
8.08
5.7
4.7
59.67
4013.93
e6/l
—
6
40
124
756
1.89
7.74
3.1
2.7
546.89
522.68
mosm/kgh2o
0.68
110
653
192
1354
1.73
7.28
2.0
1.7
18.76
20.38
nmol/l
0.83
166
1143
31
106
3.07
7.27
3.6
3.2
2.33
1.32
index
0.67
15
51
106
634
1.88
6.94
3.4
3.0
2.21
2.11
e6/l
0.04
49
294
98
579
1.89
6.64
1.7
1.9
—
—
—
0
0
9
5
18.32
6.28
4.4
1.0
26.89
15.80
u/ml
—
9
5
14
20
7.19
6.26
1.1
1.5
—
—
—
0
0
129
844
1.74
6.21
1.6
1.6
2.02
1.35
mg/l
0.76
103
668
59
298
2.13
6.19
1.4
1.5
—
—
—
0
0
16
39
4.22
6.14
2.8
2.7
14.38
12.60
index
—
8
20
29
107
2.83
5.98
1.6
1.3
225.18
285.10
ug/g
0.80
18
66
19
54
3.63
5.94
1.3
2.1
0.67
0.87
%
1.31
14
34
58
302
2.06
5.62
3.7
3.9
0.44
0.38
%
0.11
16
63
42
195
2.27
5.42
1.3
1.7
1.68
1.56
g/l
0.32
37
175
39
178
2.30
5.24
1.2
1.3
—
—
—
0
0
21
70
3.10
5.17
2.7
1.3
0.60
26.80
nmol/l
0.49
21
65
19
64
3.06
4.61
3.1
3.1
2.06
2.43
mmol/l
0.34
14
40
197
1520
1.53
4.58
3.4
3.1
1312.67
1371.14
ng/l
0.09
175
1286
57
322
1.88
4.38
4.0
4.2
0.00
0.00
%
-0.00
13
54
330
2862
1.58
4.34
5.4
4.5
—
0.20
—
0
5
56
316
1.88
4.32
3.9
4.1
0.36
0.79
%
1.26
14
64
165
1243
1.52
4.20
3.2
3.4
—
—
—
0
0
114
794
1.58
4.12
5.5
4.2
—
—
—
0
0
18
63
2.93
4.11
2.5
1.3
—
—
nmol/l
—
0
0
54
307
1.86
4.08
4.0
4.1
0.00
0.05
%
1.08
11
55
7
8
8.86
3.78
1.0
1.0
—
—
—
0
0
112
794
1.55
3.71
2.2
1.8
1061.70
1203.58
nmol/l
0.90
79
604
35
178
2.05
3.65
1.3
1.3
—
—
—
0
0
15
51
3.01
3.61
1.8
2.3
3.49
4.55
e9/l
1.01
15
51
424
3992
2.16
3.46
22.4
10.6
24.86
25.43
u/l
0.30
417
3836
239
1995
1.42
3.37
2.5
2.2
87.49
97.18
pmol/l
2.30
136
1009
61
382
1.69
3.34
3.8
3.8
7.37
7.36
ph
0.49
47
251
153
1183
1.45
3.27
4.4
4.0
0.00
0.01
estimate
0.50
64
386
338
3020
1.49
3.22
40.2
18.1
14.34
13.64
%
12.78
338
2978
11
29
3.86
3.20
1.4
1.2
—
—
—
0
0
17
68
2.56
3.08
2.2
2.5
8.61
9.80
pmol/l
0.24
17
68
7
12
5.90
3.03
1.6
2.8
—
—
—
0
0
7
12
5.90
3.03
1.4
2.8
—
148709.29
—
0
7
411
3859
1.79
2.94
26.2
13.7
—
—
—
0
0
6
9
6.74
2.87
1.3
1.7
—
—
—
0
0
70
472
1.57
2.87
3.4
2.6
7.85
4.92
e9/l
0.41
61
401
26
132
2.03
2.76
3.8
1.8
—
—
—
0
0
303
2685
1.40
2.76
5.0
4.5
—
2.91
—
0
5
44
266
1.73
2.75
2.0
2.2
9.94
11.20
g/l
1.63
44
252
16
66
2.48
2.74
1.7
2.1
59.24
58.98
%
0.03
16
66
6
10
6.06
2.70
1.0
1.8
0.67
0.59
mmol/l
—
6
10
8
20
4.05
2.58
3.1
3.0
1.00
1.05
index
—
8
20
205
1721
1.35
2.55
5.0
4.0
23.66
94.00
ng/l
1.30
168
1321
10
31
3.28
2.53
1.7
1.3
—
—
—
0
0
17
76
2.29
2.47
3.1
3.0
—
—
—
0
0
24
127
1.94
2.30
4.8
2.3
308.07
300.57
mg/l
0.02
15
40
10
35
2.90
2.22
1.7
1.3
—
—
—
0
0
273
2423
1.32
2.20
3.6
3.2
48.31
51.50
u/l
0.20
257
2244
425
4079
1.82
2.11
47.9
22.5
4.22
4.49
e12/l
18.89
417
3960
425
4079
1.82
2.11
48.0
22.5
6.70
6.71
e9/l
0.02
418
3964
29
169
1.77
2.09
2.4
2.1
0.00
0.02
estimate
—
10
51
121
962
1.35
2.08
2.0
1.8
446.92
27573498.09
pmol/l
0.94
99
787
5
10
5.04
2.07
1.0
1.1
—
—
—
0
0
12
50
2.44
2.04
3.4
2.6
—
—
—
0
0
44
294
1.55
1.91
1.4
1.4
—
—
—
0
0
237
2088
1.29
1.90
4.3
4.0
0.00
0.00
estimate
-0.00
72
412
207
1793
1.29
1.89
2.8
2.5
77.07
79.06
nmol/l
0.50
183
1572
42
279
1.56
1.87
3.0
4.7
—
—
—
0
0
65
475
1.43
1.84
1.5
1.7
—
—
—
0
0
241
2136
1.28
1.81
4.5
4.0
0.00
0.02
estimate
0.93
71
393
239
2118
1.28
1.79
4.5
4.0
0.07
0.00
estimate
0.49
75
421
57
409
1.45
1.78
1.4
1.6
—
—
—
0
0
137
1622
0.78
1.69
4.1
4.2
12.66
8.67
mg/mmol
0.40
87
1003
10
41
2.47
1.65
1.8
1.5
91.71
90.71
%
—
10
41
17
91
1.90
1.62
2.0
1.9
7.26
3.71
iu/l
—
8
40
5
14
3.60
1.62
1.0
1.1
—
—
—
0
0
136
1598
0.79
1.55
3.4
3.5
79.03
48.66
mg/l
0.56
85
1023
51
373
1.41
1.46
2.4
2.0
0.00
0.04
estimate
0.49
12
69
7
28
2.52
1.45
2.0
1.5
21.14
25.76
ng/l
—
7
28
48
348
1.42
1.44
4.1
4.1
99.84
96.01
ng/l
0.08
37
301
378
3601
1.32
1.32
6.4
5.3
1.96
2.01
mu/l
0.29
337
3276
5
18
2.80
1.29
1.0
1.3
14.38
5.85
umol/l
—
5
11
80
981
0.78
1.26
4.6
4.3
1.02
1.02
kg/l
0.57
58
636
13
70
1.88
1.25
2.3
2.9
—
—
—
0
0
8
36
2.24
1.25
1.1
1.3
—
—
—
0
0
127
1084
1.24
1.23
3.9
3.4
0.91
0.00
estimate
0.49
55
331
8
37
2.18
1.22
3.0
2.0
8.68
8.10
mmol/l
—
8
37
6
26
2.32
1.19
2.8
2.7
—
—
—
0
0
11
57
1.95
1.18
1.2
1.0
—
—
—
0
0
0
33
0.00
1.16
0.0
1.4
—
377140.39
—
0
23
5
20
2.52
1.15
1.0
1.1
—
—
—
0
0
5
111
0.44
1.14
6.8
3.8
—
—
—
0
0
62
491
1.30
1.11
3.3
3.2
5.84
5.83
kpa
0.05
62
481
14
81
1.75
1.10
1.3
1.2
—
—
—
0
0
12
66
1.84
1.10
1.2
1.1
—
—
—
0
0
55
429
1.32
1.09
2.3
2.6
4.49
7.01
ug/l
1.15
42
377
319
3003
1.22
1.09
5.6
4.1
15.28
14.99
pmol/l
1.21
292
2719
60
478
1.29
1.03
3.1
3.2
1.40
1.94
mmol/l
0.62
54
420
9
47
1.93
1.02
1.1
1.5
9.30
10.10
%
—
9
47
108
924
1.22
1.02
3.8
2.9
0.83
0.77
ug/l
0.38
81
614
103
877
1.23
1.02
3.7
4.2
100.32
318.45
ng/l
1.93
87
730
84
705
1.24
0.95
1.4
1.3
2.62
2.86
g/l
0.61
58
416
145
1620
0.84
0.91
3.2
3.4
7.33
7.51
mmol/l
0.20
117
1361
6
29
2.08
0.89
1.7
1.1
111.67
108.21
pmol/l
—
6
29
14
88
1.61
0.85
1.1
1.4
—
—
—
0
0
60
493
1.25
0.83
3.2
3.2
7.38
7.38
ph
0.17
30
300
174
1585
1.16
0.80
4.2
4.0
0.44
0.03
estimate
0.50
62
334
7
38
1.86
0.74
1.0
1.3
—
—
—
0
0
21
151
1.41
0.72
1.0
1.3
—
—
—
0
0
50
415
1.23
0.66
2.3
2.7
4.15
4.37
kpa
0.39
50
403
7
44
1.60
0.65
1.1
1.3
—
—
—
0
0
8
49
1.64
0.62
1.3
1.5
283.50
267.79
mosm/kgh2o
—
8
34
5
30
1.67
0.61
1.0
1.6
102.00
83.91
ng/l
—
5
30
33
264
1.27
0.60
1.2
1.3
—
—
—
0
0
29
228
1.29
0.60
2.3
2.5
—
—
—
0
0
8
52
1.55
0.59
1.6
1.4
36.33
25.84
g/l
—
8
42
63
542
1.19
0.59
1.2
1.3
185.45
504.30
titre
4.30
11
135
20
149
1.36
0.58
1.3
1.4
8.44
10.66
g/l
2.92
14
131
11
161
0.68
0.58
1.5
1.6
0.20
0.31
mg/l
—
5
71
6
35
1.72
0.58
1.0
1.1
—
—
—
0
0
6
36
1.68
0.57
2.5
2.1
—
—
—
0
0
6
98
0.61
0.52
1.8
2.0
198.67
212.92
pmol/l
—
6
92
21
162
1.31
0.51
1.2
1.2
—
—
—
0
0
174
1630
1.11
0.48
7.1
4.4
2.92
1.99
ug/l
1.81
152
1469
17
222
0.76
0.48
2.9
3.2
1.01
1.02
ratio
0.58
12
207
45
384
1.19
0.48
2.0
3.5
196.95
199.21
ng/l
0.02
38
356
5
82
0.61
0.46
1.8
2.2
1.74
4.81
mmol/24h
—
5
76
26
210
1.25
0.46
2.2
1.9
—
—
—
0
0
7
49
1.44
0.46
1.0
1.2
—
—
—
0
0
7
49
1.44
0.46
1.0
1.2
—
—
—
0
0
7
51
1.38
0.44
1.0
1.2
—
—
—
0
0
7
51
1.38
0.44
1.0
1.2
—
—
—
0
0
13
95
1.38
0.44
2.2
2.5
1.52
1.78
mg/l
0.46
13
80
33
276
1.21
0.43
3.4
3.7
7.43
7.42
ph
1.63
25
227
16
122
1.32
0.43
1.4
1.5
0.24
0.23
g/l
0.34
16
117
5
32
1.57
0.42
3.0
4.1
6.65
9.09
mg/l
—
5
25
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
5
36
1.39
0.38
3.2
2.3
—
—
—
0
0
31
262
1.20
0.38
2.1
2.4
0.58
0.61
%
0.28
31
262
177
1681
1.09
0.36
3.8
3.6
6.26
6.27
ph
0.05
94
916
5
80
0.62
0.35
1.0
1.4
—
—
—
0
0
6
43
1.40
0.35
1.3
1.3
—
—
—
0
0
49
436
1.14
0.33
2.1
2.2
227.00
129.70
ug/g
0.88
42
338
6
46
1.31
0.33
1.2
1.3
—
—
—
0
0
129
1365
0.92
0.30
3.4
3.6
—
—
—
0
0
83
771
1.09
0.28
1.3
1.3
43.51
39.39
iu/ml
0.10
22
225
13
161
0.80
0.27
1.1
1.1
—
—
—
0
0
169
1756
0.94
0.24
2.0
2.0
1.29
1.31
mmol/l
0.11
131
1456
6
84
0.71
0.24
1.3
1.5
0.68
0.85
nmol/l
—
6
67
148
1418
1.07
0.23
2.4
2.2
367.84
239.57
u/l
0.33
140
1330
386
3906
0.91
0.23
5.8
6.6
2.55
2.60
mmol/l
0.62
335
3602
5
38
1.32
0.23
5.4
2.1
14.52
16.90
%
—
5
38
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
5
39
1.29
0.23
1.8
1.4
—
20241.65
—
0
20
5
41
1.22
0.22
1.6
1.3
0.50
1.62
nmol/l
—
5
33
0
11
0.00
0.21
0.0
8.2
—
8.16
—
0
11
8
104
0.77
0.21
1.1
1.2
104.63
53.30
e6/l
—
8
82
0
12
0.00
0.21
0.0
6.6
—
25.21
—
0
12
0
12
0.00
0.21
0.0
10.5
—
906.00
—
0
12
8
105
0.76
0.21
1.3
1.3
27272.25
1327.56
e6/l
—
8
84
5
43
1.16
0.21
1.8
2.6
—
—
—
0
0
87
822
1.07
0.21
1.3
1.3
2.62
1.40
u/ml
0.27
26
228
0
14
0.00
0.20
0.0
2.8
—
—
—
0
0
9
114
0.79
0.20
1.1
1.2
—
—
—
0
0
9
115
0.78
0.20
1.0
1.3
983.67
497.20
mg/l
—
9
107
6
50
1.20
0.20
1.0
1.2
—
—
—
0
0
39
357
1.10
0.19
1.6
1.5
—
—
—
0
0
12
143
0.83
0.19
1.7
1.4
—
—
—
0
0
6
53
1.13
0.18
1.3
1.3
—
—
—
0
0
7
61
1.15
0.17
1.1
1.4
317.57
357.31
pmol/l
—
7
51
8
69
1.16
0.16
1.1
1.3
—
—
—
0
0
13
151
0.86
0.16
14.6
10.3
—
—
—
0
0
6
78
0.77
0.15
1.3
1.2
13.22
18.76
u/l
—
6
66
378
3813
0.94
0.14
5.1
5.6
1.40
1.46
mmol/l
2.21
328
3504
12
103
1.17
0.14
1.0
1.1
—
—
—
0
0
38
355
1.08
0.13
2.6
2.4
0.48
0.41
e6/l
0.08
38
336
385
3820
1.06
0.12
5.6
5.7
6.05
6.07
mmol/l
0.09
336
3484
35
327
1.08
0.12
2.4
2.5
6.00
6.00
ph
0.01
21
221
30
321
0.93
0.10
1.7
2.8
122.97
130.36
g/l
0.88
30
315
5
46
1.09
0.09
1.2
1.2
—
—
—
0
0
6
56
1.07
0.08
2.2
2.8
—
—
—
0
0
49
510
0.96
0.08
1.5
1.4
—
—
—
0
0
367
3647
1.03
0.08
4.3
4.7
1.29
1.28
mmol/l
0.06
313
3317
382
3841
0.96
0.07
5.2
5.7
4.41
4.51
mmol/l
1.21
336
3551
8
74
1.08
0.07
1.0
1.1
—
—
—
0
0
30
284
1.06
0.07
1.2
1.2
—
—
—
0
0
18
194
0.92
0.07
4.3
3.9
—
—
—
0
0
7
80
0.87
0.07
1.3
1.8
—
—
—
0
0
12
129
0.93
0.03
2.2
2.3
285.05
98.73
ug/min
—
6
76
22
213
1.03
0.01
1.3
1.2
23.40
94.21
u/ml
—
5
89
70
708
0.99
0.01
1.3
1.3
12.72
12.45
u/ml
0.01
30
248
20
198
1.01
0.00
1.3
1.3
—
—
—
0
0
10
101
0.99
0.00
1.0
1.3
3.90
3.85
mmol/l
—
10
96
376
3756
1.01
0.00
6.8
7.3
39.26
40.08
mmol/mol
1.18
343
3500
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
85
0.94
-0.00
1.0
1.2
1.64
1.51
g/l
—
8
85
0
6
0.00
-0.00
0.0
2.7
—
23.50
—
0
6
0
5
0.00
-0.00
0.0
2.6
—
7.80
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
74.67
—
0
6
8
87
0.92
-0.00
1.1
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.7
—
18.76
—
0
9
8
89
0.90
-0.00
1.0
1.2
0.97
0.92
g/l
—
8
89
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
3.00
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
65.20
—
0
5
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
76.11
—
0
9

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_GASTRINT_STROM – Gastrointestinal stromal tumor and sarcoma

GWS hits: 1

This endpoint is excluded from FinRegistry analyses (omitted endpoint).